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ABSTRACT 
 
Steroid hormones, estrogens, androgens, progestins, glucocorticoids, and 
mineralocorticoids, regulate a variety of biological functions related to development, cell 
proliferation, differentiation, reproduction, and metabolism. The effects of the steroid 
hormones are mediated by steroid receptors, trans-acting transcription factors, which bind 
to regulatory sequences on target genes upon ligand binding, and either stimulate or 
repress gene expression. During recent years, a group of coregulatory proteins modulating 
steroid receptor responses in target gene regulation has been described. In gene 
inactivation experiments, some of the coregulatory proteins have been found to play 
essential roles in steroid receptor-mediated signaling, fertility, and fetal development. 
Small nuclear RING finger protein SNURF/RNF4, originally identified by its interaction 
with androgen receptor (AR), interacts with several transcription factors, such as TATA-
binding protein (TBP) and promoter specificity protein 1 (Sp1). SNURF possesses a C-
terminal RING finger domain, a motif typical of many E3 ubiquitin ligases and tumor 
suppressor proteins.  
 
Despite several in vitro interaction and expression studies reported during recent years, the 
biological function of SNURF has remained largely unknown. However, the expression of 
SNURF to high levels in testis suggests a role in reproduction and fertility. To gain insight 
into the role of SNURF in reproduction and testicular cancer, the expression of SNURF 
mRNA and protein was investigated during murine prenatal gonad development, in rodent 
postnatal folliculogenesis and spermatogenesis, and in human normal testis and testicular 
germ cell tumors. In murine fetal gonads, the expression of SNURF mRNA was detected 
from E10.5 dpc onwards in both sexes. SNURF mRNA was expressed to high levels in 
round and elongating spermatids in postnatal human and rat testis, and in oocytes of 
preantral follicles in postnatal murine ovary, respectively. Transcription from the murine 
SNURF promoter was governed by a single promoter, which showed very strong basal 
activity in reporter gene assays in mammalian cells. The proximal GC box at +9 nt of the 
SNURF promoter was identified as the main element governing transcription from the 
murine SNURF gene, and the Wilms’ tumor 1 (WT1) gene product was found as one of 
the potential activators of the murine SNURF promoter. Furthermore, the expression of 
SNURF mRNA was regulated by testosterone in vivo in rat testis and by gonadotropins 
and estrogen in vivo in rodent ovary. SNURF protein colocalized with estrogen receptor β 
(ERβ) protein in fetal and postnatal male germ cells. Down-regulated expression of 
SNURF and ERβ mRNA and protein was detected in human testicular germ cell tumors, 
suggesting a role for SNURF and estrogen signaling in the pathogenesis of testicular germ 
cell cancer.  
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ABBREVIATIONS 
 
AF  activation function 
AP-1  activating protein-1 
AR  androgen receptor 
CBP  CREB (cyclic AMP-responsive element -binding protein) -binding protein 
CREM  cyclic AMP-responsive element modulator 
DBD  DNA-binding domain 
DES  diethylstilbestrol 
dpc  days post coitum 
DRIP  vitamin D receptor-interacting protein 
E2  estradiol 
EDS  ethylene dimethane sulphonate  
EMSA  electrophoretic mobility shift assay 
ER  estrogen receptor 
FSH  follicle-stimulating hormone 
GR  glucocorticoid receptor 
HAT  histone acetyltransferase 
hCG  human chorionic gonadotropin 
HDAC  histone deacetylase 
HRE  hormone response element 
LBD  ligand-binding domain 
LH  luteinizing hormone 
MAA  methoxyacetic acid 
N-CoR  nuclear receptor corepressor 
NF-κB  nuclear factor κB 
NLS  nuclear localization signal 
Nrip1  Nuclear receptor -interacting protein 1 
PGC  primordial germ cell 
PIAS  protein inhibitor of activated STAT 
PMSG  gonadotropin from pregnant mare serum 
PPAR  peroxisome proliferator-activated receptor 
PR  progesterone receptor 
RNF4  ring finger protein 4 
RT-PCR reverse transcription polymerase chain reaction  
SMRT  silencing mediator for retinoic acid receptor and thyroid receptor 
SNURF small nuclear RING finger protein 
Sp1  promoter specificity protein 1 
SRC  steroid receptor coactivator 
SUMO  small ubiquitin-like modifier 
T  testosterone 
TBP  TATA-binding protein 
TGC  testicular germ cell cancer 
TRAP  thyroid receptor-associated protein 
WT1  Wilms’ tumor 1 gene product 
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REVIEW OF THE LITERATURE 
 
Introduction 
 
During fertilization, the fusion of sperm and egg, the specific combinations of genes 
encoded in the parental chromosomes are brought together to give life to an offspring in 
mammals. The female egg and male sperm originate from primordial germ cells (PGC) 
and differentiate into oocytes and gonocytes, respectively, prenatally. The germ cells gain 
full maturity during postnatal development in response to hormone signals and gonadal 
transcription factors. Disturbances during gonad development are likely to disrupt fertility 
and predispose to gonadal tumorigenesis, and thus better understanding of the mechanisms 
underlying gonadal development is mandatory for management of infertility and gonadal 
cancer. In this review, fetal and postnatal gonad development, testicular tumors, male 
infertility, steroid receptor signaling mechanisms, and coregulators are discussed.  
 
Sex Determination and Fetal Gonad Development 
 
Sex determination in mammals is a complex process, which is usually divided to 
determination of the gonad and its differentiation. During the first phase of gonad 
development, an indifferent bipotential primordium is established in both female and male 
mice from the thickening of coelomic epithelium on the ventrolateral surface of the 
mesonephros between embryonic day 10.5 and 11.5 (E10.5-11.5) dpc (for review, Capel 
2000, Koopman et al. 2001, McLaren 2000, Swain and Lovell-Badge 1999, Veitia et al. 
2001). The genital ridge is composed of the somatic cells derived from the mesonephros 
and proliferating primordial germ cells (PGC), which have migrated via the hindgut and 
mesonephros from the extraembryonic mesoderm at the base of the allantois. Expression of 
Wilms’ tumor 1 (WT1) and steroidogenic factor-1 (SF1) begins in the bipotential ridge by 
E10.0 dpc. SF1 is an orphan nuclear receptor that regulates genes involved in steroid 
synthesis in both the gonad and the adrenal gland. Impairment of WT1 and SF1 genes 
resulted in complete regression of the initially formed gonadal ridges by E14.5 dpc and 
E12.5 dpc, respectively (Kreidberg et al. 1993, Luo et al. 1994). The gonad initially 
develops in a non-sex-specific manner, being morphologically identical in XX and XY 
embryos up until E12.0 dpc. 
 
At E10.5-11.0 dpc, Sry, the sex determining gene on Y chromosome, begins to be 
expressed in the male genital ridge, and it guides the initial testis determination by 
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triggering differentiation of pre-Sertoli cells (Clarkson and Harley 2002, Koopman et al. 
2001). In addition, Sry-related Sox9 (Sry-like HMG-box protein 9) is expressed in the 
male gonad from E11.5 dpc onwards persisting there throughout the life, while it is not 
seen in the ovary (Clarkson and Harley 2002). SF1 and Sox9 activate the expression of the 
anti-müllerian hormone gene (AMH, also called Müllerian inhibiting substance, MIS), 
which induces the regression of the female urogenital tract forming Müllerian ducts in 
males (de Santa Barbara et al. 1998, Shen et al. 1994) (Fig. 1). Transgenic experiments 
where XX mice carrying the Sry and Sox9 genes develop as males have established the 
necessity of these factors in testis determination (Koopman et al. 1991, Vidal et al. 2001). 
By E12.5 dpc, the Sertoli cells have encircled germ cells and formed testis cords, 
surrounded by peritubular myoid cells. Other somatic cells in the developing testis are 
Leydig cells, which produce testosterone, critical for the development of Wolffian ducts to 
male urogenital tract and the formation of all male secondary sexual characteristics (Fig. 1, 
Table 1).  
 
At E13.5 dpc, oogonia in the murine ovary enter the meiotic prophase arresting at 
diplotene stage, while the majority of the germ cells within the testicular cords undergo 
mitotic arrest. Dax1, an orphan nuclear receptor, is expressed concomitantly with Sry in 
both sexes, but it is down-regulated in the testis and stays in the ovary during further 
prenatal gonad development (Swain et al. 1996). Dax1 has been thought to act 
antagonistically to Sry in a dosage-sensitive manner, since duplication of the Xp21 locus 
bearing the Dax1 gene resulted in XY sex reversal (Swain et al. 1998). However, murine 
Dax1 was essential for normal spermatogenesis in later life (Jeffs et al. 2001). In addition, 
Wnt-4 factor was involved in the suppression of Leydig cell formation in the ovary (Vainio 
et al. 1999). Wnt-4 null mutant female mice were masculinized (no Müllerian ducts and 
persistence of Wolffian structures), while the male phenotype was normal (Vainio et al. 
1999).  
 
 
Table 1: Timeline for murine gonad development 
dpc  
E9.5-E11 PGCs migrate from yolk sac to posterior body wall, where they induce formation of genital 
ridges. 
E11.0 Cells from the coelomic epithelium of mesonephros proliferate.   
E12.5 Sertoli cells encircle the germ cells and form testicular cords. 
E13.5 Testicular morphology recognizable. Female oogonia enter I meiosis, while male germ cells 
enter mitotic arrest. Development of external genitalia begins. 
Modified from Rey R and Picard JY, Baillieres Clin Endocrinol Metab, 1998. 
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Fig. 1 Development of the male and female internal genitalia from bipotential gonadal primordial.  
Pre-Sertoli cells and Leydig cells in the fetal testis produce Müllerian inhibiting substance (MIS) and 
testosterone (T), respectively. MIS induces the regression of Müllerian ducts in the male and T stimulates the 
development of the male urogenital tract from the Wolffian ducts and the formation of external genitalia. 
Modified from Rey and Picard, Baillieres Clin Endocrinol Metab, 1998.   
 
Postnatal Gonad Development 
 
Ovarian folliculogenesis  
 
During folliculogenesis, the primordial follicles consisting of an oocyte and a single layer 
of squamous granulosa cells develop into large preovulatory antral follicles, which contain 
several layers of columnar granulosa cells surrounding the oocytes (for review, Epifano 
and Dean 2002, Matzuk et al. 2002, Richards 2001) (Fig. 2). Growth of the primordial 
follicles to primary follicles requires the Kit ligand produced by the granulosa cells and c-
kit receptor expressed in the egg as well as growth and differentiation factor 9 (GDF-9), an 
oocyte-specific member of TGFβ growth factor family (Elvin et al. 1999). GDF-9 null 
mice exhibited failed organization of theca cells, abnormal oocyte growth, and arrested 
follicle maturation to the primary follicle stage (Elvin et al. 1999, Richards 2001).  
 
The initiation of follicle growth occurs independently of pituitary gonadotropins, but 
follicle-stimulating hormone (FSH) is mandatory for the final growth of the preovulatory 
follicles. FSH promotes granulosa cell proliferation and stimulates expression of CYP450 
aromatase in the granulosa cells (Richards 2001). The granulosa cells are not only the site 
Indifferent gonads
mesonephros
Müllerian duct
Wolff ian duct
Male Testis Female Ovary
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Wolffian duct:
epididymis,
vas deferens,
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of action of FSH in the control of follicular growth, but they also produce estrogens by 
conversion from androgens diffused from the neighboring theca cells (Fig. 4). The 
granulosa cells also provide nutrients and chemical messengers critical for the oocyte 
maturation, and the oocyte itself promotes granulosa cell proliferation and differentiation 
(Matzuk et al. 2002). Luteinizing hormone (LH) enhances theca cell differentiation and 
androgen production. The oocytes have entered the first meiosis already prenatally and 
have arrested at diplotene of the first meiotic division. LH surge induced by the increasing 
plasma estrogen levels triggers the completion of the first meiotic division, terminates the 
follicular growth by turning on genes, such as progesterone receptor (PR) and 
prostaglandin synthase-2, controlling ovulation and luteinization (Richards 2001) (Fig. 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Ovarian folliculogenesis. Communication between the oocyte and the surrounding granulosa cells is 
established perinatally in primordial follicles, where a single layer of squamous granulosa cells is gathered 
around the egg. Along with the progression of folliculogenesis, granulosa cells proliferate and differentiate in 
response to FSH to form several layers of columnar cells around the oocyte in preovulatory follicles. Oocyte-
granulosa cell communication is mediated by secreted paracrine factors and gap junctions. After the LH 
surge, the first meiosis is completed, and the follicle wall is ruptured resulting in the release of the oocyte. 
The second meiotic division is completed only after fertilization. Factors critical for each follicular 
development stage are indicated. AR; androgen receptor, c-kitR; c-kit receptor, ER; estrogen receptor, FIGα; 
factor in the germline α, FSHR; follicle-stimulating hormone receptor, GC; granulosa cell, GDF; growth and 
differentiation factor, KitL; Kit ligand, LHR; luteinizing hormone receptor, PR; progesterone receptor, 
Theca; Theca cell. Modified from Matzuk et al. Science 2002. 
        FIGα KitL, c-KitR, 
GDF-9 
GC: FSHR, AR, ERα, ERβ 
Theca: LHR 
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Spermatogenesis 
 
Spermatogenesis is a complex multi-step process, in which diploid spermatogonia 
differentiate into mature haploid spermatozoa in the epithelium of the seminiferous tubules 
during the postnatal testis development (for review, Grootegoed et al. 2000, Hecht 1998). 
Spermatogenesis is often divided into proliferation, meiotic, and spermatogenic phases 
(Russell et al. 1990). In the proliferative phase, most spermatogonia, which have arisen 
from the PGCs and gonocytes, located close to the basement membrane of the tubule, enter 
mitosis to give rise to a reserve of undifferentiated stem cells, and only a minority of 
spermatogonia become diploid preleptotene spermatocytes. During the meiotic phase, the 
diploid preleptotene cells pass through two meiotic divisions to produce haploid round 
spermatids. The long prophase of the first meiotic division lasting approximately three 
weeks in rodent testis, is initiated at leptotene spermatocytes and is subsequently followed 
by zygotene phase, in which homologous sister chromatids are paired and a synaptonemal 
complex is formed. In the ensuing pachytene spermatocytes, genetic material is 
recombined (crossing-over), and in diplotene spermatocytes it is segregated to sister 
chromatids. During the meiotic cell divisions, the germ cells remain connected by 
cytoplasmic bridges, and the syncytia move towards the tubular lumen. In differentiation 
or spermiogenic phase, the round spermatids undergo a series of molecular and 
morphological changes to generate mature spermatozoa. Changes in the composition of 
chromatin resulting in the formation of the spermatid head, acrosome development, and 
flagellum formation, take place during spermiogenesis to allow transmission of the 
paternal chromosomes to the oocyte at fertilization (Fig. 3).  
 
Germ cell development takes place in close association with the somatic Sertoli cells of the 
seminiferous epithelium (Fig. 3). Sertoli cell-germ cell interaction provides physical 
support, tight junctions, growth factors, and nutrients critical for germ cell development 
(for review, Griswold 1995, Griswold 1998). Importantly, the Sertoli cells form blood-
testis barrier, which allows them to create a microenvironment in the tubular compartment, 
in which meiotic divisions and postmeiotic modifications take place. The associations 
between the Sertoli cells and the germ cells at different phases of maturation are referred to 
as stages and comprise the cycle of the seminiferous tubule (Leblond and Clermont 1952). 
Groups of spermatogonia enter the spermatogenic process at regular intervals, and the 
cycle is defined as a time interval between the appearance of germ cells at the same stage 
at the defined point of the tubule. In mice and men, spermatogenesis lasts for 35 and 70 
days, respectively.   
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Fig. 3 Top: The Flow of Spermatogenesis. During the fetal period, primordial germ cells (PGC) 
differentiate into gonocytes, which give rise to spermatogonia right after birth. Spermatogonia proliferate to 
maintain a pool of undifferentiated germ cells or, more rarely, give rise to preleptotene primary 
spermatocytes. The primary spermatocytes proceed via the first and second meiotic divisions to become 
secondary spermatocytes and round spermatids, respectively. During spermiogenesis, chromatin is 
compacted, and acrosome and flagellum develop to generate mature haploid spermatozoa.  Modified from 
Sassone-Corsi, Cell, 1997.  
Bottom: Organization of the developing germ cells and Sertoli cells in the seminiferous tubules in 
testis. Spermatogonia, spermatocytes, and round spermatids are seen in successively higher levels within the 
seminiferous epithelium. Sertoli cells and spermatogonia contact the basement membrane. Sertoli cells reach 
from the base of the tubule to the lumen and encircle the developing germ cells. Tight junctions, gap 
junctions, and desmosomes connect Sertoli cells to each other to create the blood-testis barrier and a 
microenvironment for germ cell maturation. Modified from Russell et al., 1990. 
PRIMORDIAL 
GERM CELL 
GONOCYTE SPERMATOGONIA PRIMARY 
SPERMATOCYTE
SECONDARY 
SPERMATOCYTE
SPERMATID SPERMATOZOON
SPERMATOGONIA 
Fetal testis Postnatal testis
stem cell 
renewal pathway 
mitosis 1st meiosis 2nd meiosis     spermiogenesis
BASAL LAMINA 
Tubule lumen
Interstitial compartment 
ELONGATING 
SPERMATID 
ROUND SPERMATID 
SPERMATOCYTE
SPERMATOGONIA 
MYOID CELL 
TIGHT 
JUNCTION 
SERTOLI 
CELL 
PROLIFERATIVE MEIOTIC SPERMIOGENIC 
  Review of the literature 
 
 15
After the completion of germ cell development, the mature spermatozoa are released to the 
tubular lumen and proceed to the epididymis for capacitation, a process of biochemical 
changes for the development of sperm motility and capablity of fertilization (Grootegoed 
et al. 2000). Differentiation of germ cells is governed by the cyclic hormonal stimulation 
by the hypothalamic-pituitary axis, which secretes two anterior pituitary hormones LH and 
FSH (McLachlan et al. 1996, Zirkin 1998) (Fig.4). In the testis, LH and FSH receptors are 
found only in the Leydig and Sertoli cells, respectively, and their actions are mediated 
from these cells to developing germ cells by paracrine signaling. Leydig cells produce 
testosterone (T) in response to LH. T then diffuses into the seminiferous tubules and gives 
rise to high tubular testosterone concentration important for germ cell maturation. T and 
FSH induce Sertoli cells to secrete glycoproteins, proteases, and other paracrine substances 
essential for differentiating germ cells (Griswold 1995, Griswold 1998, Zirkin 1998). FSH 
is required for the neonatal Sertoli cells to divide. However, FSH-deficient mice are fertile 
(Kumar et al. 1997, Meacham et al. 1996, Singh and Handelsman 1996). Likewise, FSH 
receptor-deficient male mice are fertile but produce poor quality sperm (Krishnamurthy et 
al. 2000). Moreover, men homozygous for an inactivating mutation of the FSH receptor 
gene show spermatogenic failure (Tapanainen et al. 1997). The Sertoli cells have the 
capacity to support only a limited number of maturing germ cells, and apoptosis plays an 
important role in the regulation of sperm numbers and elimination of defective gametes. 
Both T and FSH suppress germ cell apoptotic death and enhance germ cell survival (Billig 
et al. 1995, Erkkilä et al.  1997, Tapanainen et al. 1993). 
 
Estrogens are synthesized from androgens by action of CYP450 aromatase in Leydig cells, 
Sertoli cells, and germ cells resulting in high estrogen levels in both the interstitial tissue 
and tubular fluid (Carreau and Levallet 1997, Genissel et al. 2001, Janulis et al.  1998, 
Nitta et al. 1993, O’Donnell et al. 2001). Important actions of testosterone on developing 
germ cells are mediated via Sertoli cells. The male germ cells lack androgen receptor (AR) 
and estrogen receptor α (ERα), but estrogen receptor β (ERβ) is detected in male gametes 
(Carreau 2001, Enmark et al. 1997, Iwamura et al. 1994, Suarez-Quain et al. 1999, van 
Roijen et al. 1995). However, βERKO male mice with disrupted ERβ gene are fertile and 
possess normal sperm counts (Couse et al. 1999, Krege et al. 1998). In αERKO male mice, 
reduced fertilization capability of spermatozoa, dilatation of efferent ductules, and defects 
in fluid reabsorption hindering the entry of sperm to epididymis, result in infertility (Eddy 
et al. 1996, Hess et al. 1997, Hess et al. 2000, Lee et al. 2000). The phenotype of 
αβERKO male mice resembles that of αERKO mice (Couse et al. 1999, Dupont et al. 
2000). Interestingly, ovaries of adult αβERKO females manifest postnatal sex reversal and 
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exhibit follicle transdifferentiation to structures resembling seminiferous tubules of the 
testis including Sertoli cell-like cells (Couse et al. 1999). Estradiol (E2) influences the 
negative feedback to the hypothalamus and the pituitary via conversion from androgens, 
and it controls the secretion of LH and FSH (Lindzey et al. 1998, O’Donnell et al. 2001). 
Thus, absence or inappropriate exposure to estrogens could disturb the balance of the 
hypothalamic-pituitary axis. In addition, estrogens play a role in testicular descent, the 
hormone-regulated migration of testes from the abdominal wall to scrotum, by regulating 
fetal Leydig cell gene expression (Hutson et al. 1997, Nef and Parada 2000, O’Donnell et 
al. 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Hypothalamic-pituitary-gonadal axis in the regulation of gonad function. Testis: Inhibin, a 
protein hormone secreted by the Sertoli cells, feeds back to the anterior pituitary and mainly inhibits 
secretion of FSH. Secretion of LH and gonadotropin-releasing hormone (GnRH) is inhibited mainly by 
testosterone (T) secreted from the Leydig cells. T, acting locally, is essential for spermatogenesis. Ovary: 
Estradiol (E2), in low plasma concentration during the early and middle follicular phase, feeds back 
negatively to the hypothalamus and the anterior pituitary to decrease secretion of GnRH and LH, 
respectively. Inhibin, secreted from the granulosa cells, acts on the pituitary to inhibit the secretion of FSH. 
Estrogen, in high plasma levels preceding ovulation, triggers the secretion of LH surge from the pituitary 
(positive feed-back). High plasma concentration of progesterone during the luteal phase and pregnancy 
inhibits the hypothalamic neurons that secrete GnRH. Androgens produced in response to LH in theca cells 
diffuse into granulosa cells, in which they are converted to estrogens by CYP450 aromatase. Modified from 
Vander et al., Human Physiology, McGraw Hill, 2001.  
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Marked stage-specific gene regulation underlies the morphological changes of developing 
germ cells during spermatogenesis (for review, Sassone-Corsi 1997, Steger 1999). Various 
promoters display differential activity in male gametes due to the presence of testis-
specific transcription factors (Foulkes et al. 1992). Some general transcription factors, such 
as TATA-binding protein (TBP), TFIIB, and RNA polymerase II are differentially 
regulated in germ cells and accumulate in postmeiotic round spermatids where high 
transcriptional activity takes place (Schmidt and Schibler 1995). In addition, many 
ubiquitously expressed genes generate testis-specific isoforms by the usage of alternative 
promoters, splicing, or polyadenylation (Daniel and Habener 1998, Moilanen et al. 1998b, 
Schmidt et al. 1997). The hypothalamic-pituitary axis controls the postmeiotic gene 
activation by enhancing accumulation of the CREM activator protein CREMτ in the male 
germ cells in response to FSH (Foulkes et al. 1993). CREMτ is a consensus cAMP 
response-element (CRE) binding protein, that is highly expressed from round spermatids 
onwards and regulates transcription from several postmeiotic genes, such as protamines, 
calspermin, and transition protein (Kistler et al. 1994, Sassone-Corsi 1998, Sun et al. 
1995). In addition to CREMτ activator, the CREM gene encodes transcriptional repressors 
CREMα, β, and γ, which are expressed to low levels in premeiotic germ cells (Foulkes et 
al. 1992). Targeted disruption of the CREM gene results in complete arrest of the germ cell 
differentiation at the first step of spermiogenesis (Blendy et al. 1996, Nantel et al. 1996). 
Recently, male germ cell-specific transcriptional coregulators have also been identified, as 
exemplified by the LIM-only protein ACT, that enhances CREM-mediated transcription in 
the germ cells (Sassoni-Corsi 2002). 
 
Transcription ceases several days before the completion of spermatogenesis because of the 
condensation of the haploid genome to a volume of approximately 5% of that of somatic 
cell nuclei (Ward and Coffey 1991, Ward 1993). In round spermatids, the histones and 
non-histone proteins are replaced by transition proteins, and in elongating spermatids, the 
transition proteins are removed and replaced by protamines, the principal basic nuclear 
proteins in spermatozoa (Dadoune 1995, Oliva and Dixon 1991, Wouters-Tyrou et al.  
1998). Translational regulation plays a significant role in maturing spermatids: a number of 
proteins appear in the late stages of spermiogenesis and must be translated from mRNA in 
postmeiotic germ cells (for review, Steger 1999). Translational regulation is exemplified 
by direct repression of mRNA by RNA-binding proteins, such as 70-kDa poly-A binding 
protein (PABP), and activation by deadenylation of long poly-A tails (Gu et al. 1995, 
Venables and Eperon 1999). 
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Testicular Tumors and Male Infertility 
 
Testicular germ cell cancer (TGC) 
 
Testicular germ cell cancers (TGC) comprise a heterogenous group of neoplasms 
originating from cells belonging to the male germ cell lineage (Dearnaley et al. 2001). 
Seminoma recapitulates some aspects of spermatogenesis, and it is the most common type 
of TGC accounting for about half of the cases. Nonseminomas, including embryonal 
carcinoma, yolk sac tumor, teratoma, and teratocarcinoma, represent progeny of 
pluripotent embryonic cells (for review, Dearnaley et al. 2001) (Table 2). Although TGCs 
comprise only approximately 1% of all human malignancies, they are the most frequent 
cancers in young men between ages 20-40 (Chaganti and Houldsworth 2000). In Finland, 
approximately 70-90 testicular cancers are diagnosed annually (Black et al. 1997, 
Sundström et al. 2001).  
 
Table 2: Classification of testicular cancer types. 
Germ cell tumors   
Seminomas  50-60 % 
 Classic (82-85 %)
 Anaplastic (5-10 %) 
 Spermatocytic (2-12 %) 
Nonseminomas   
 Embryonal carcinoma 20-25 % 
 Teratocarcinoma 25-30 % 
 Teratoma 5-10 % 
 Yolk sac tumor <1% 
Stromal tumors   
 Leydig cell tumor 1-3 % 
 Sertoli cell tumor <1% 
 Mixed tumor  
Modified from Nurmi et al., Urologia, Duodecim, 2002. 
 
Several risk factors for TGC development have been identified, including cryptorchidism, 
testicular dysgenesis, Klinefelter’s syndrome, prior history to germ cell cancer, and a 
positive family history (Bosl and Motzer 1997, Chaganti and Houldsworth 2000, Forman 
et al. 1992). The onset of the disease at early adulthood suggests that the initiating event 
occurs prenatally, and endogenous or environmental estrogens affecting the embryonic 
testis have been suggested to participate in the pathogenesis of TGC (Henderson et al. 
1979, Sharpe 2003, Weir et al. 2000). Gene amplification is a common mechanism of 
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increased gene expression in human cancers. The most common cytogenetic aberration in 
TGC is the presence of an isochromosome (duplication) of the short arm of chromosome 
12 in up to 80% of all TGC cases (Chaganti and Houldsworth 2000). In accordance with 
the overpresentation of 12p, mRNA encoded by the cyclin D2 gene, located at 12p13, was 
over-expressed in 69% of the TGCs by a mean factor of 7.9 as judged by semi-quantitative 
RT-PCR assay (Schmidt et al. 2001). Cyclin D2 along with the CDK4 protein regulates 
phosphorylation of the RB tumor suppressor protein and controls the G1-S cell cycle 
checkpoint (Schmidt et al. 2001). In addition, specific gains and losses from several other 
chromosomal regions, e.g. overpresentation of 17q, have been reported in TGC (Skotheim 
et al. 2002). Furthermore, the first mouse model of classical testicular seminoma has been 
identified in transgenic mice over-expressing glial cell-derived neurotrophic factor 
(GDNF), a member of TGFβ superfamily expressed also in Sertoli cells (Meng et al. 
2001). 
 
The treatment of testicular tumors consists of radical orchiectomy (removal of the testis), 
and chemotherapy and/or radiotherapy depending on the tumor stage (Dearnaley et al. 
2001, Nurmi et al. 2002). To date, cisplatin-containing chemotherapy has enabled cure 
rates >90-95% in lower-stage testicular malignancies (Dearnaley et al. 2001, Nurmi et al.  
2002). However, liver, bone, or central nervous system metastases, high alpha-fetoprotein 
(>1000 ng/ml) or human chorionic gonadotropin (hCG>10 000 IU/l) marker levels, or the 
presence of primary mediastinal tumor indicate poorer prognosis with 70% 5-year survival 
rate among the Finnish testicular cancer patients (Aareleid et al. 1998, Mäenpää et al. 
1996, Nurmi et al. 2002). 
 
Male infertility  
 
Approximately 10% of couples trying to conceive suffer from subfertility, with 
approximately one third of the cases deriving from male factor infertility. Potential causes 
of male infertility comprise varicocele, undescended testes, antibodies against 
spermatozoa, microdeletions in the Y-choromosomal AZF region, testicular and genital 
tract infections, chromosomal disorders such as Klinefelter’s syndrome (47XXY), systemic 
disease, external factors (such as drugs), radiotherapy, chemotherapy, and insufficient or 
excess reproductive hormone production. However, most often the reason for the poor 
quality of semen remains undetermined (for review, Cahill and Wardle 2002, Ford 2001, 
Hirsh 2003, Khorram et al. 2001). Patients suffering from hypogonadotropic 
hypogonadism as a major cause of infertility benefit from medication (Khorram et al. 
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2001). Furthermore, introduction of intracytoplasmic sperm injection (ICSI) has 
dramatically improved the treatment of male factor infertility (Braude and Rowell 2003, 
Cahill and Wardle 2002, Ford 2001, Khorram et al.  2001). 
  
Nuclear Receptors 
 
Nuclear receptor superfamily 
 
The actions of lipophilic hormones, including steroids, retinoids, vitamin D, and thyroid 
hormone, are mediated through the conserved family of nuclear receptors which function 
as ligand-regulated, DNA-binding transcription factors (for review, Aranda and Pascual 
2001, Beato et al. 1996, Mangelsdorf et al. 1995, McKenna et al.  1999). Fourty-eight 
human genes encoding members of the nuclear receptor superfamily sharing extensive 
homology have been identified to date (Mangelsdorf et al. 1995, McKenna and O’Malley 
2002b). Identification of genes with structural features similar to those found in nuclear 
receptors has lead to the discovery of orphan receptor members, such as PPAR, ERR, 
Nurr1, LXR, and PXR, of the family without prior knowledge of their putative ligands 
(Giguère 1999). Recently, ligands have been found for many orphan receptors: LXR binds 
oxysterols, FXR bile acids, PXR pregnanes, and PPAR several fatty acids and 
prostaglandins (Giguère 1999). This chapter focuses mainly on the steroid receptors, 
especially androgen receptor (AR) and estrogen receptors (ER).  
 
Androgen receptor (AR) 
 
Physiological roles of androgens 
 
Androgen receptor (AR) mediates the responses of androgens that affect a male body in 
multiple ways. Androgens regulate the development of sex organs, the growth of facial, 
body, and pubic hair, the enlargement of vocal cords, the growth of the prostate, the 
production of sperm, and the development of muscle strength, and masculine behavior 
(Mooradian et al. 1987, Quigley et al. 1995). AR has two physiological ligands, 
testosterone and 5α-dihydrotestosterone (DHT), which is converted from testosterone by 
5α-reductase in target cells (Mooradian et al. 1987). In certain cells, testosterone is 
converted to 17β-estradiol by CYP450 aromatase. After binding the androgen ligand, AR 
regulates the bodily functions by interacting with hormone response elements (HRE) 
located in the regulatory regions of the target genes. This leads to transcriptional activation 
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or repression of the regulated genes (Beato et al. 1996). Among genes activated by AR are 
those encoding rat probasin, mouse sex-limited protein (slp), human glandular kallikrein 
(KLK2), and prostate-specific antigen (PSA) (Adler et al. 1992, Murtha et al. 1992, 
Rennie et al. 1993, Riegman et al. 1991). 
 
Functional domains of androgen receptor 
 
Androgen receptor consists of an amino-terminal region (region A/B), a DNA-binding 
domain (DBD, region C), a hinge region (region D), and a ligand-binding domain (LBD, 
region E)(for review, Gelmann 2002).  The DBD and LBD of AR share 77-80% and 50-
55% homology, respectively, with GR, PR, and MR. The amino-terminal modulatory A/B 
domain of AR is the most variable in both size and sequence among the steroid receptors. 
The A/B domain harbors a ligand-independent transactivation function (AF-1), 
communicates with other parts of the receptor and interacts with several coregulator 
proteins, such as SRC-1 and CBP (Alen et al. 1999, Ikonen et al. 1997). The DBD of the 
steroid receptors is the most conserved region, and it confers ability to recognize specific 
target sequences and activate genes. The DBD of AR is composed of two zinc finger 
modules comprising some 70 amino acid residues and a carboxyl-terminal extension that 
spans approximately 25 residues. The second zinc finger participates in receptor 
dimerization and, along with the carboxyl-terminal region, is involved in HRE recognition 
(Freedman 1992, Gelmann 2002, Schoenmakers et al. 1999).  
 
The D domain, which is less well conserved among the nuclear receptors, serves as a hinge 
between the DBD and the LBD, allowing rotation of the DBD. The hinge region contains 
the major part of the nuclear localization signal, which mediates the transfer of AR from 
the cell cytoplasm to its site of action in the nucleus (Jenster et al. 1993, Zhou et al. 1994). 
The LBD is the site of specific, high-affinity binding of the androgen ligand. Recently, the 
three-dimensional structure of the AR LBD has been determined (Matias et al. 2000, Sack 
et al. 2001). Like other steroid receptors, AR LBD is composed of 12 α-helices that form a 
ligand-binding pocket. After agonist binding, helix 12 is positioned over the pocket to 
enclose the ligand (Sack et al. 2001). The LBD of AR possesses the second activation 
function (AF-2) and interacts with coregulators (Ikonen et al. 1997). Deletion of AR LBD 
results in a constitutively active receptor, indicating strongly that AF-1 harbors the main 
transactivation activity of AR (Jenster et al. 1993, Gelmann 2002). 
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Androgen receptor gene and disease 
 
The human gene for AR encompasses approximately 80 kb and is mapped to a conserved 
region on chromosome Xq11-12 (Lubahn et al. 1988, Quigley et al. 1995). AR protein is 
approximately 110 kDa in size, and it is polymorphic due to the polymeric glutamine and 
proline repeats in the first exon of the AR gene. The glutamine (CAG) repeat length 
polymorphism contributes to the pathogenesis of Kennedy’s disease (also called spinal and 
bulbar muscular atrophy (SBMA)), that is an adult-onset, slowly progressing motoneuron 
disease (LaSpada et al. 1991, Yong et al. 2000). The number of CAG repeats increases 
with the severity of the Kennedy’s disease, and affected males show variable degrees of 
gynecomastia, testicular atrophy, and subfertility (LaSpada et al. 1991). In contrast, short 
CAG repeat length of AR was associated with more aggressive prostate cancer occurrence, 
earlier age of disease onset, and likelihood of prostate cancer recurrence (Bratt et al. 1999, 
Giovannucci et al. 1997, Hardy et al. 1996, Nam et al. 2000). The AR gene was amplified 
in 30% of hormone-refractory prostate cancers, and mutations in the LBD of AR were 
shown to broaden ligand specificity of the receptor in recurrent prostate cancer (Gregory et 
al. 2001). Loss of AR function in genetic (XY) males leads to complete androgen 
insensitivity syndrome with an external phenotype of a sterile woman, undescended testes, 
and lack of ovaries and uterus (Yong et al. 2000). In testicular feminized mice (Tfm) with a 
spontaneous single point mutation in the AR gene resulting in truncation and inactivation 
of AR, testicular migration and spermatogenesis are impaired (Charest et al. 1991, Lyon 
and Hawkes 1970, Lyon et al. 1975). Interestingly, AR knockout male mice (ARKO), 
generated by using the cre-lox conditional knockout strategy, showed female-like external 
genitalia, severely reduced testicular size, lowered testosterone concentration, Leydig cell 
hyperplasia, and arrested spermatogenesis at pachytene spermatocyte stage (Yeh et al. 
2002).  
 
Estrogen receptors (ER) 
 
Estrogens have traditionally been connected to female reproduction, but during recent 
years they have been reported to play a role in the male reproduction, bone metabolism, 
and physiology of the cardiovascular and central nervous systems (Enmark and Gustafsson 
1999). Estrogen signals are mediated by two estrogen receptors, estrogen receptor 
α (ERα) and estrogen receptor β (ERβ), of which only ERβ is expressed in the male germ 
cells (Fig. 5) (Enmark et al. 1997, Kuiper et al. 1996). The human ERβ gene is localized to 
a different chromosome than the ERα gene, to 14q22-24 (Enmark et al. 1997). Recently, 
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an ERβ variant ERβcx/ERβ2, a dominant negative mutant against the ERα without an 
apparent ligand-binding ability, was identified (Gaskell et al. 2003, Ogawa et al. 1998, 
Saunders et al. 2002). In the human testis, abundant amounts of ERβ protein were detected 
in primary spermatocytes and early round spermatids (Enmark et al. 1997, Pelletier and El-
Alfy 2000).  
 
Male βERKO mice were fertile and showed hyperplastic foci in the prostate of young adult 
mice (Weihua et al. 2001). Female βERKO mice were subfertile due to the early atresia of 
preantral follicles and ovulatory failure and exhibited defects in differentiation of ductal 
side branches and alveoli in mammary glands after puberty (Dupont et al. 2000, Förster et 
al. 2002, Krege et al. 1998, Weihua et al. 2001). Furthermore, ERβ was required for the 
migration of cortical neurons during late embryonic development of the brain and 
differentiation of pluripotent hematopoietic progenitor cells (Shim et al. 2003, Wang et al. 
2003). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Comparison of the human estrogen receptor α, estrogen receptor β, and estrogen receptor 
βcx/β2 structures. Human ERβ shows 97% and 54% homology to the DBD and LBD of human ERα, 
respectively. ERβcx/ERβ2 is identical with ERβ for the first 469 amino acids, but differs from it in the 
replacement of the last 61 amino acids by a unique 26-amino acid sequence. Modified from Enmark and 
Gustafsson, J Int Med, 1999. 
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Transcriptional control by nuclear receptors 
 
Activating signals and ‘transcriptional cross-talk’ 
 
In contrast to peptide hormones, which communicate with their intracellular targets 
through surface receptors and second messenger signaling pathways, lipophilic steroid 
hormones bind to intracellular steroid receptors. Ligand binding induces a conformational 
change in the steroid receptor, that dissociates from receptor-associated inhibitory heat 
shock proteins and facilitates receptor dimerization, nuclear transport, and interaction with 
target DNA motifs, resulting in transcriptional regulation of the target gene (for review, 
Aranda and Pascual 2001) (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. 6 Outline of androgen receptor (AR) action in cell.  1. The lipohilic testosterone ligand (T) diffuses 
into the cell. In some cells, testosterone is converted to 5α-dihydrotestosterone (DHT) by 5α-reductase. 2. 
After ligand binding, AR undergoes a conformational change and dissociates from receptor-associated 
inhibitory heat shock proteins, including hsp90. 3. Ligand binding facilitates nuclear translocation of AR, 
receptor dimerization, and interaction with hormone response elements (HRE) and coactivators, resulting in 
enhanced or repressed transcription of the target gene. PIC; preinitiation complex. 
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A pair of palindromic 6-bp consensus AGAACA motifs, separated by three spacer 
nucleotides, is recognized by androgen, progesterone, glucocorticoid, and 
mineralocorticoid receptors, while the motif AGGTCA is preferentially recognized by 
estrogen receptors (Glass 1994). Steroid receptors usually bind to HRE as homodimers, 
while several orphan and non-steroidal nuclear receptors, such as thyroid and vitamin D 
receptors, bind to their HREs as heterodimers with retinoic acid receptor X (RXR) (Glass 
1994).  Interaction of ligand-bound steroid receptor with its HRE often results in 
transcriptional activation of the target gene. However, also negative HREs that bind 
liganded receptors resulting in hormone-mediated transrepression of the gene have been 
identified, such as for GR in the pro-opiomelanocortin and prolactin gene promoters 
(Drouin et al. 1989, Sakai et al. 1988). A subset of nuclear receptors, such as thyroid and 
retinoic acid receptors, repress basal transcription when bound to HRE in the absence of 
the ligand. The repressor activity is due to the binding of corepressors to the unliganded 
receptors. Binding of the hormone ligand to the receptor releases corepressors and leads to 
transactivation (Casanova et al. 1994, Tong et al. 1996). 
 
Steroid receptors interact with sequence-specific transcription factors through binding to 
nearby or overlapping binding sites. This is exemplified by the communication between 
GR and heterodimeric AP-1 transcription factors on a composite site containing both GRE 
and AP-1 elements at the proliferin promoter. The interaction results in GR-mediated 
transrepression or transactivation by AP-1 depending upon whether a Fos-Jun or Jun-Jun 
complex occupies the AP-1 site (Miner and Yamamoto 1992). Steroid receptors also affect 
transcriptional activity through positive or negative interference with other transcription 
factors without binding to the specific hormone response elements, referred to as 
‘transcriptional cross-talk’ (for review, Beato et al. 1996, Göttlicher et al. 1998). For 
example, the collagenase type I gene is repressed by mutual antagonism between GR and 
AP-1 independent of DNA binding (Schüle et al. 1990, Jonat et al. 1990). In addition, AR 
was able to elicit both transactivation and transrepression of AP-1 factors without 
interacting directly with DNA-binding elements (Kallio et al. 1995). Moreover, NF-κB 
transcription factors participate in cross-talk with steroid receptors, as exemplified by 
mutual repression between AR and NF-κB factors by competition for a common cellular 
factor, the CBP coactivator (Aarnisalo et al. 1998, Dumont et al. 1998, Palvimo et al. 
1996).  
 
Nuclear receptors are also activated or repressed by posttranslational covalent 
modifications, such as phosphorylation, acetylation, ubiquitination, and sumoylation. 
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Steroid receptors are phosphorylated even in the absence of ligand, but ligand binding 
often increases the phosphorylation status of the receptors leading to enhancement of 
steroid receptor-mediated transcription (Kato et al. 1995, Kuiper et al. 1993, Nazareth and 
Weigel 1996, Orti et al. 1992, Shao and Lazar 1999, Weigel 1996). AR is phosphorylated 
on several sites, such as S81, S94, and S650, of which the phosphorylation of S650 seems 
to be necessary for full AR activity (Brinkmann et al. 1999, Zhou et al. 1995). 
Phosphorylation of AR is necessary for ubiquitination and degradation of AR by Mdm2 E3 
ligase (Lee and Chang 2003). Mutation of the AR lysine residues to abrogate acetylation 
repressed transactivation of AR-regulated gene promoters, inhibited coactivation by 
several cofactors, increased corepressor N-CoR binding to the receptor, and inhibited 
MEKK1-induced apoptosis in prostate cancer cells (Fu et al. 2000, Fu et al. 2002). The AR 
is also covalently modified by small ubiquitin-like modifier 1 (SUMO-1) resulting in 
attenuation of AR-elicited transactivation (Poukka et al. 2000c).  
 
Targeting of chromatin remodeling complexes 
 
Two classes of chromatin remodeling factors play critical roles in transcriptional activation 
by nuclear receptors: ATP-driven nucleosome remodeling complexes and factors 
possessing histone acetyltransferase activity (for review, Narlikar et al. 2002, Workman 
and Kingston 1998, Wu 1997). Chromatin remodeling complexes, such as 
SWI/SNF/BRG1 and imitation of SWI (ISWI), alter the nucleosome structure in an ATP-
dependent manner to facilitate promoter access, transcription factor binding, and 
transcription initiation (Narlikar et al. 2002, Owen-Hughes et al. 1996, Workman and 
Kingston 1998, Wu 1997). For example, progesterone receptor targeted ISWI-containing 
complexes to the mouse mammary tumor virus (MMTV) promoter and glucocorticoid 
receptor tethered the SWI/SNF complex to the chromatinized templates containing 
glucocorticoid response elements (DiCroce et al. 1999, Ostlund Farrants et al. 1997). 
Histone acetyltransferases covalently modify histones by decreasing their positive charge 
by acetylation, which is thought to result in weakened interaction with DNA and more 
accessible chromatin for transcription factor binding (Struhl 1998, Workman and Kingston 
1998, Wu 1997). Histone acetylation usually increases transcriptional activity while 
hypoacetylation often correlates with transcriptional inactivity (Pazin and Kadonaga 1997, 
Workman and Kingston 1998). Factors with intrinsic histone acetyltransferase activity 
include members of the general transcription machinery, such as TAFII250, and 
coactivators of nuclear receptor action, including p/CAF (p300/CBP-associated factor), 
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SRC family members, CREB -binding protein (CBP), and p300 (Glass and Rosenfeld 
2000).  
 
Coregulators 
 
Introduction 
 
Steroid receptors interact directly with components of the basal transcription machinery in 
vitro (Lee et al. 2000, McEwan and Gustafsson 1997). In addition, coregulators, defined 
broadly as cellular factors recruited by nuclear receptors that complement receptor function 
mediating the cellular response to endocrine signals, have been identified during recent 
years. Most of the coregulators were initially identified by their stimulative or repressive 
effects on nuclear receptor action in transient transfection assays, and the proteins are 
called as coactivators and corepressors, respectively (for review, Beato et al. 1996, 
Freedman 1999, Glass and Rosenfeld 2000, Hermanson et al. 2002, McKenna et al. 1999, 
McKenna and O’Malley 2002a,b, Xu et al. 1999). Chromatin immunoprecipitation studies 
have shown that nuclear receptors and coregulators assemble on target promoters in a 
sequential and rapidly cycling dynamic fashion (Shang et al. 2000). 
 
Coactivators modulate nuclear receptor function in a variety of ways. Coactivators recruit 
additional cofactors to DNA-bound nuclear receptors, as exemplified by the recruitment of 
CBP by SRC family proteins  (Demarest et al. 2002, Leo and Chen 2000, Yao et al. 1996). 
Several coactivators, such as SRC-1, SRC-3, CBP/p300, and p/CAF, acetylate 
nucleosomal histones at promoter regions to derepress chromatin structure (Chan and La 
Thangue 2001, Chen et al. 1997, Spencer et al. 1997). In addition, coactivator-associated 
arginine methyltransferase (CARM) and protein arginine methyltransferase (PRMT-1) 
function as histone methylases further relieving chromatin compaction (Chen et al. 1999, 
Koh et al. 2001). Some coactivators, such as the human TRAP/DRIP (TR-associated 
protein/VDR-interacting protein) complex, may recruit RNA polymerase II to nuclear 
receptor target promoters (Malik and Roeder 2000).  
 
Coregulators interact with various domains of nuclear receptors. SRC family, Nrip1, 
AIB3/RAP250/ASC-2, and PBP/TRAP220 proteins interact with the LBD of nuclear 
receptors via α-helical motifs related to Leu-X-X-Leu-Leu (LXXLL motif or NR box) (for 
review, Cavailles et al. 1995, Feng et al. 1998, Freedman 1999, Glass and Rosenfeld 2000, 
Heery et al. 1997, Lee et al. 1998, Leo and Chen 2000, McKenna et al. 1999). 
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Table 3: Examples of Coregulators     
Coregulator Enzymatic activity Reference 
AIB3/ASC-2/RAP250 - Lee et al. 1999, Caira et al. 2000 
ANPK Serine/threonine kinase Moilanen et al. 1998a 
ARIP4 ATPase Rouleau et al. 2002 
CARM methyltransferase Koh et al. 2001 
CBP histone acetyltransferase Bannister & Kouzarides 1996 
E6-AP E3 ubiquitin ligase  Nawaz et al. 1999, Scheffner et al. 1994 
GT198 - Ko et al. 2002 
N-CoR - Alland et al. 1997 
Nrip1 - Cavailles et al. 1995 
p300 histone acetyltransferase Eckner et al. 1994 
PBP/TRAP220 - Zhu et al. 1997 
PIAS1/GBP E3 SUMO-1 ligase Liu et al. 1998, Kotaja et al. 2002a 
PIAS3 E3 SUMO-1 ligase Chung et al. 1997, Kotaja et al. 2002a 
PIASxα/ARIP3 E3 SUMO-1 ligase Moilanen et al. 1999, Kotaja et al. 2002a 
PIASxβ/Miz1 E3 SUMO-1 ligase Wu et al. 1997, Kotaja et al. 2002a 
PIASy E3 SUMO-1 ligase Liu et al. 1998, Kotaja et al. 2002a 
PRMT-1 methyltransferase Chen et al.1999 
SMRT - Nagy et al.1997 
SNURF/RNF4 E3 ubiquitin ligase ? Moilanen et al.1998b, Häkli et al. unpubl.
SRC-1/NcoA-1 histone acetyltransferase Spencer et al.1997 
SRC-2/TIF2/GRIP1/NcoA-2 - Hong et al.1997 
SRC-3/AIB1/ACTR/RAC3/TRAM-1 histone acetyltransferase Anzick et al. 1997 
 
 
SNURF/RNF4, ANPK, ARIP3/PIASxα, and ARIP4 were identified by their interaction 
with the AR DBD and hinge region (Moilanen et al. 1998a, Moilanen et al. 1998b, 
Moilanen et al. 1999, Rouleau et al. 2002). In addition, GT198, a tissue-specific 
coactivator expressed to high levels in testis, interacts with the DBD of nuclear receptors 
(Ko et al. 2002). The best characterized corepressors, nuclear receptor corepressor (N-
CoR) and silencing mediator of retinoid and thyroid hormone receptors (SMRT), repress 
transcription by binding to the DBD of the DNA-bound unliganded thyroid and retinoid 
receptors (Chen and Evans 1995, Horwitz et al. 1996, Hörlein et al. 1995) and also interact 
with unliganded and antagonist bound LBD of nuclear receptors. Steroid receptors, such as 
estrogen and progesterone receptors, bind N-CoR and SMRT in the presence of antagonists 
4-hydroxytamoxifen and RU486, respectively, and corepressor recruitment is essential for 
the full antagonist activity (Lavinsky et al. 1998). N-CoR and SMRT, that are related 
structurally and functionally recruit cellular histone deacetylase (HDAC) complexes 
enhancing chromatin compaction (Alland et al. 1997, Kao et al. 2000, Nagy et al. 1997). 
The corepressors are recruited to nuclear receptors by CoRNR signature motif, resembling 
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the LXXLL motif of coactivators (Hu and Lazar 1999, Nagy et al. 1999). In the following 
chapters, some of the most extensively studied coregulators are described in more detail. 
 
CBP and p300 
 
CREB-binding protein and p300 are functionally conserved histone acetyltransferases, and 
coactivate nuclear receptor action (Bannister and Kouzarides 1996, Chakravarti et al. 
1996, Chan and La Thangue 2001, Eckner et al. 1994, Lundblad et al. 1995, Ogryzko et al. 
1996). CBP and p300 acetylate not only histones but also transcription factors, such as 
p53, AR, ERα, TFIIE, and TFIIF, and function as coactivators for several signaling 
pathways involving CREB, AP-1, p53, and STATs (Arias et al. 1994, Bhattacharya et al. 
1996, Fu et al. 2000, Gu and Roeder 1997, Horvai et al. 1997, Imhof et al. 1997, 
Jancknecht and Hunter 1996, Zhang et al. 1996). Only limiting amounts of CBP and p300 
reside in cells, and several signal transducers compete for their interaction, as exemplified 
by the inhibition of AP-1 activity through CBP-recruiting nuclear receptors (Kamei et al. 
1996). CBP and p300 function as bridging proteins by contacting nuclear receptors and 
basal transcription factors, form a scaffold for the assembly of multiprotein complexes, and 
may increase the local concentration of additional histone acetyltransferases, such as SRC-
1 and p/CAF (Chan and La Thangue 2001, Jenster et al. 1997, Kee et al. 1996, Spencer et 
al. 1997, Yang et al. 1996). In addition, CBP and p300 participate in the in vivo 
polyubiquitination, but not monoubiquitination, of p53 (Grossman et al. 2003).  
 
Gene-disrupted p300-/-, CBP-/-, and p300+/-CBP+/- mouse embryos died around embryonic 
day 10 due to the defects in neural tube closure and heart development (Yao et al. 1998). 
In addition, p300-/- murine embryonic fibroblasts showed retarded cell proliferation and 
were defective in retinoic acid-dependent transcription (Yao et al. 1998). CBP+/- mouse 
embryos presented abnormal skeletal patterning with similarities to patients with 
Rubinstein-Taubi syndrome, a disorder of mental retardation, craniofacial and skeletal 
defects, and increased incidence of neoplasia caused by mutations in one CBP gene locus 
in humans (Petrij et al. 1995). In addition, studies on CBP+/- mice suggest that CBP 
functions as a tumor suppressor in the hematopoietic system (Kung et al. 1999). 
Translocation between acetyltransferases MOZ and CBP resulting in MOZ-CBP fusion 
protein has been found in patients suffering from acute myeloid leukemia (Borrow et al. 
1996). Moreover, biallelic mutations of p300 were found in patients with colorectal and 
gastric carcinomas (Gayther et al. 2000, Giles et al. 1998, Muraoka et al. 1996).  
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p160 coactivators 
 
Three related genes, encoding approximately 160-kDa proteins, SRC1/NcoA-1, 
TIF2/GRIP1/NcoA-2, and p/CIP/AIB1/ACTR/SRC-3/TRAM-1/RAC3, constitute the p160 
or SRC family of nuclear receptor coactivators (Anzick et al. 1997, Chen et al. 1997, Hong 
et al. 1997, Leo and Chen 2000, Li et al. 1997, Onate et al. 1995, Takeshita et al. 1997, 
Torchia et al. 1997). The p160 factors possess highly conserved amino-terminal basic 
helix-loop-helix (bHLH) and PAS domains, and the carboxyl-terminus of SRC-1 and SRC-
3 harbor histone acetyltransferase (HAT) activity (Chen et al. 1997, Spencer et al. 1997). 
The carboxyl-terminus of the p160 factors acts as a platform for assembly of arginine 
methyltransferases CARM1 and PRMT1, that enhance nuclear receptor activity by 
methylating histones (Chen et al. 1999, Koh et al. 2001). 
 
Mice with the disrupted SRC-1 gene were viable and fertile, but responded only partially 
to thyroid and steroid hormones in the development and growth of target organs, such as 
testis, uterus, prostate, and mammary gland (Qi et al. 1999, Weiss et al. 1999, Xu et al. 
1998). The relatively subtle defects seen in the SRC-1 knockout mice may be explained by 
the compensatory over-expression of transcriptional intermediary factor 2 (TIF2) (Xu et al. 
1998, Wang et al. 2000). TIF2/GRIP1 null mutant mice showed impaired fertility in both 
sexes (Gehin et al. 2002). Male hypofertility was caused by teratozoospermia (i.e., 
abnormalities in morphology of the spermatozoa) and age-dependent testicular 
degeneration, while female subfertility derived from defects in placental development 
(Gehin et al. 2002). TIF2 knockout mice possessed normal thyroid function, but double 
heterozygous disruption of TIF2 and SRC-1 resulted in thyroid hyposensitivity (Takeuchi 
et al. 2002, Weiss et al. 2002). In addition, gene deletion experiments have revealed that 
SRC-1 and TIF2 modulate energy metabolism in the white and brown adipose tissue 
(Picard et al. 2003).  
 
Furthermore, the inv(8)(p11q13) resulted in a fusion between TIF2 and MOZ genes in 
human acute myeloid leukemia patients, and interaction of the MOZ-TIF2 fusion protein 
with CBP was essential for transformation (Carapeti et al. 1998, Deguchi et al. 2003). 
Inactivation of the gene encoding SRC-3, which is highly amplified and over-expressed in 
primary breast cancers, resulted in dwarfism, delayed puberty, abnormal female 
reproductive function, and mammary gland growth retardation (Xu et al. 2000, Yuan et al. 
2002). These data underscore the biological significance of the SRC family proteins in the 
developmental and hormonal regulation.  
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Nrip1 
 
Nuclear receptor -interacting protein 1 (Nrip1, formerly RIP140), which was originally 
identified as an estrogen-dependent cofactor of mouse ERα, is widely expressed in tissues 
and cells (Cavailles et al. 1995, Lee et al. 1998). Nrip1 inhibits the activity of several 
nuclear receptors, and its expression was regulated by estradiol in breast cancer cells 
(Cavailles et al. 1995, Subramaniam et al. 1999, Thenot et al. 1999, Treuter et al. 1998). In 
the ovary, the highest expression level of Nrip1 was detected in granulosa cells, whereas 
lower levels were detected in the thecal and interstitial compartments (White et al. 2000). 
Furthermore, Nrip1 expression was temporally regulated in the corpora lutea at different 
stages of pregnancy (Leonardsson et al. 2002). Null mutation of Nrip1 led to female 
infertility due to a complete ovulatory failure (White et al. 2000). In addition, 
approximately 50% of the oocytes were entrapped in luteinizing follicles in superovulated 
heterozygous mice, underscoring the need of the absolute level of Nrip1 for ovulation 
(White et al. 2000). However, embryo and ovarian transplantation experiments 
demonstrated that by by-passing ovulation, Nrip1-/- mice were capable of establishing and 
maintaining pregnancy (Leonardsson et al. 2002). 
 
PPARγ –binding protein (PBP)/TRAP220 
 
The TRAP/DRIP complex that interacts with thyroid and vitamin D receptors is recruited 
to nuclear receptors by an LXXLL motif of PPARγ-binding protein (PBP)/ 
DRIP205/TRAP220 (Fondell et al. 1996, Fondell et al. 1999, Rachez et al. 2000). Several 
proteins of the TRAP/DRIP complex are components of mediator, a protein assembly 
associating with RNA polymerase II, and the TRAP/DRIP complex probably acts as a 
bridging protein recruiting the polymerase to nuclear receptor target promoters (Rachez et 
al. 1998, Rachez et al. 1999).  
 
Disruption of the PBP/TRAP220 coactivator gene resulted in embryonic lethality at E11.5 
dpc due to defects in placental vascular network, heart failure, and impaired neurological 
development with extensive apoptosis (Ito et al. 2000, Zhu et al. 2000). In addition, 
deletion of the PBP gene lead to paucity of retinal pigment, defective lens formation, 
excessive systemic angiogenesis, a deficiency in the number of megakaryocytes, and an 
arrest in erythrocyte differentiation (Crawford et al. 2002). Moreover, heterozygous mice 
showed growth retardation, dysfunction of the pituitary-thyroid axis, and transcriptional 
impairment in the testis and in the brain (Ito et al. 2000). Murine embryonic fibroblasts 
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derived from the TRAP220-/- embryos showed significant decrease in thyroid receptor 
function, and TRAP220 was also required for PPARγ2-mediated adipogenesis (Ge et al. 
2002, Ito et al. 2000). Furthermore, PBP/TRAP220 was amplified and overexpressed in 
breast carcinomas (Zhu et al. 1997, Zhu et al. 1999).   
 
AIB3/RAP250/ASC-2 
 
Amplified in breast cancer-3 (AIB3)/RAP250/ASC-2 is a coactivator of several nuclear 
receptors, including thyroid hormone receptors, retinoic acid receptor α, PPARα, PPARγ, 
ERα, and GR (Lee et al. 1999, Caira et al. 2000). The human AIB3 gene is located to a 
highly amplified chromosomal region 20q11-12, and AIB3 was amplified in 10% of breast 
cancers, 30% of colon cancers, and 13% of lung cancers studied (Lee et al. 1999). Since 
AIB3 interacts with several transcription factors, such as nuclear receptors, serum response 
factor (SRF), AP-1, and NF-κB, it could contribute to malignant transformation by 
affecting multiple signal transduction pathways governing cell proliferation and 
differentiation (Lee et al. 2000).  
 
Murine embryos with disrupted AIB3 gene died during E9.75-13.5 dpc due to the cardiac 
hypoplasia and defects in placental vascular network and nervous system development 
(Antonson et al. 2003, Kuang et al. 2002). The placental defects included failure of 
labyrinthine development, dilation of maternal blood sinuses, massive erythrophagocytosis 
by trophoblasts, and alteration of trophoblast populations (Antonson et al. 2003, Kuang et 
al. 2002). In microinjection studies, anti-ASC-2 antibody abrogated the ligand-dependent 
transactivation by retinoic acid receptor. Moreover, the repression was fully reversible by 
coinjection of ASC-2 expression plasmid, thus confirming the essential role of AIB3/ASC-
2 in nuclear receptor-mediated signaling in mammalian cells (Lee et al. 1999). In addition, 
AIB3 was required for full PPARγ action in murine fibroblasts (Antonson et al. 2003, 
Kuang et al. 2002). 
 
PIAS protein family 
 
PIAS1/GBP, PIAS3, PIASy, PIASxβ/Miz1, and PIASxα/ARIP3,  members of the protein 
inhibitor of activated STAT (signal transducer and activator of transcription) family, 
interact with steroid receptors (Chung et al. 1997, Kotaja et al. 2000, Kotaja et al. 2002a, 
Liu et al. 1998, Moilanen et al. 1999, Wu et al. 1997). STAT transcription factors are 
activated by several cytokines, that bind to their cell surface receptors resulting in tyrosine 
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phosphorylation of STATs. After phosphorylation, STATs dimerize and translocate into 
the nucleus to induce transcription from their target genes (Levy and Darnell 2002). PIAS1 
and PIAS3 inhibit DNA binding of STAT1 and STAT3 factors, respectively, whereas 
PIASy represses STAT1 and AR activity without affecting their DNA binding (Chung et 
al. 1997, Liu et al. 1998). 
 
PIAS proteins comprise a conserved group of putative zinc finger proteins with 60-80% 
homology in their amino acid sequences. They contain two LXXLL motifs and a N-
terminal SAF box/SAP domain (SAF-A, Acinus, PIAS) (Moilanen et al. 1999, Tan et al. 
2002). PIAS1, PIASy, and PIASxα function as E3 ligases for small ubiquitin-like 
modifier-1 (SUMO-1) in sumoylation, a covalent posttranslational modification, of p53, 
TIF2/GRIP1, Sp3, LEF1, c-Jun, and AR (Kahyo et al. 2001, Kotaja et al. 2002b, Nishida 
and Yasuda 2002, Ross et al. 2002, Sachdev et al. 2001, Sapetschnig et al. 2002, Schmidt 
and Müller 2002). In addition, STAT1 is a substrate for SUMO-1 modification but 
inhibition of STAT1 by PIAS1 did not require sumoylation of STAT1 itself (Rogers et al. 
2003, Ungureanu et al. 2003). Sumoylation proceeds by a three-step enzyme pathway 
resembling ubiquitylation (for review, Hochstrasser 2001, Jackson 2001, Kim et al. 2002, 
Müller et al. 2001). SUMO-1 is likely to target proteins to subcellular and subnuclear 
compartments, influence the activity of transcription factors, facilitate protein-protein 
interactions, and inhibit ubiquitylation.  
 
PIAS3 is widely expressed in various tissues, whereas the PIAS1, PIASy, PIASxα/ARIP3, 
and PIASxβ/Miz1 are predominantly expressed in testis (Chung et al. 1997, Liu et al. 
1998, Santti et al. 2003, Tan et al. 2000, Tan et al. 2002, Yan et al. 2003). Inactivation of 
Su(var)2-10, a Drosophila PIAS orthologue, disrupted mitotic chromosome condensation 
and organization of interphase chromatin (Hari et al. 2001). In addition, yeast Siz1 (PIAS 
homologue) interacted with the condensin complex, suggesting for a role in chromatin 
condensation (Strunnikov et al. 2001). Furthermore, PIAS1 was down-regulated in RAS-
transformed fibroblasts, repression of PIASy was associated with stage-progression in 
chronic myeloid leukemia, and PIAS3 was down-regulated in anaplastic lymphoma 
(Ohmine et al. 2001, Zhang et al. 2002, Zuber et al. 2000). 
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Table 4: Homozygous null mutations of coregulators 
Targeted gene Phenotype 
CBP and p300 Embryonic lethality at E10.5 dpc, defects in neural tube closure and heart 
 development 
SRC-1 Partial resistence to thyroid and steroid hormones 
TIF2/GRIP1 Impaired fertility in both sexes, teratozoospermia, age-dependent testicular 
 degeneration, defects in placental development 
SRC-3/AIB1/ACTR/ Female subfertility, dwarfism, delayed puberty, mammary gland growth 
RAC3/TRAM-1/p/CIP retardation 
Nrip1 Female infertility, complete ovulatory failure 
TRAP220/PBP Embryonic lethality at E11.5 dpc, defects in placental vascular network, cardiac 
 failure and impaired neurological development, arrest in erythrocyte  
 differentiation, excessive systemic angiogenesis  
ASC-2/RAP250/AIB3 Embryonic lethality at E9.75-E13.5 dpc, cardiac hypoplasia, defects in placental 
 vascular network and nervous system development 
 
 
Small nuclear RING finger protein SNURF/RNF4 
 
Structure of SNURF 
 
Small nuclear RING finger protein (SNURF)/Ring finger protein 4 (RNF4), a steroid 
receptor coregulator, was originally identified in a yeast two-hybrid screen using AR DBD 
as a bait (Moilanen et al. 1998b). SNURF is phylogenetically unique to mammals: its 
homologues are not present in Saccharomyces cerevisiae or Caenorhabditis elegans. Rat 
SNURF is composed of 194 amino acids, of which approximately 30% are charged 
(Chiariotti et al. 1998, Moilanen et al. 1998b) (Fig. 7). SNURF possesses an N-terminal 
bipartite nuclear localization signal and a C-terminal C3HC4 type of RING (really 
interesting new gene) finger (Fig. 7) (Borden and Freemont 1996, Borden 2000, Joazeiro 
and Weissman 2000, Saurin et al. 1996). RING finger motifs are found in several proteins 
involved in developmental regulation (polycomb group proteins Bmi-1, RING1), apoptosis 
(inhibitors of apoptosis c-IAP1, c-IAP2), oncogenesis (proto-oncogene proteins PML, 
BRCA1), neurodegenerative disease (familial juvenile Parkinson disease product Parkin), 
viral pathogenicity (Herpes simplex virus protein IE110), regulation of cell cycle (APC11), 
and protein degradation (E3 ubiquitin ligases APC11, BRCA1) (Everett and Maul 1994, 
Futreal et al. 1994, Gmachl et al. 2000, Haupt et al. 1991, Kakizuka et al. 1991, Kanno et 
al. 1995, Rothe et al. 1995, Satijn et al. 1997, Shimura et al. 2000, van der Lugt et al. 
1994).  
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Fig. 7 Rat SNURF is composed of 194 amino acids. SNURF possesses an N-terminal bipartite nuclear 
localization signal (designated as a black box) and a C3HC4 -type of RING finger in its carboxyl-terminus. 
Modified from Moilanen et al., Mol Cell Biol, 1998. 
 
Interaction partners of SNURF 
 
SNURF interacts in vitro with several transcription factors, such as Sp1 (promoter 
specificity protein 1), SBPB (activator of stromelysin gene expression), PATZ (POZ-AT 
hook-zinc finger protein), Gscl (Goosecoid-like), TRPS1, and TATA-binding protein 
(TBP) (Fedele et al. 2000, Galili et al. 2000, Kaiser et al. 2003, Lyngso et al. 2000, 
Moilanen et al. 1998b, Pero et al. 2002, Poukka et al. 2000a). SNURF binds to the DBD 
and hinge regions of steroid receptors and enhances their transactivation functions in 
mammalian cells (Moilanen et al. 1998b, Saville et al. 2001). For example, SNURF and 
TATA-binding protein (TBP) synergistically enhanced ERα-mediated transactivation in 
ZR-75 human breast cancer cells (Saville et al. 2001). Moreover, SNURF facilitated 
nuclear import of AR and retarded its export from nuclei of mammalian cells after 
testosterone withdrawal (Poukka et al. 2000b). In addition, SNURF stimulated 
transcription from minimal reporter gene constructs bearing consensus elements for 
transcription factors Sp1 and AP-1, and enhanced binding of Sp1 and SPBP to their 
cognate DNA targets in vitro (Lyngso et al. 2000, Moilanen et al. 1998b, Poukka et al. 
2000a). SNURF also stimulated transcription from the rat luteinizing hormone-β promoter 
(LHβ) by interacting with Sp1 and steroidogenic factor-1 (SF1) (Curtin et al., unpublished 
results). Binding of SNURF to AR, Gscl, TRPS1, and SF1 was mediated via the regions 
outside the RING finger, whereas for the interaction with TBP, Sp1, PATZ, and SPBP, an 
intact RING finger region was needed (Kaiser et al. 2003, Lyngso et al. 2000, Pero et al. 
2002, Poukka et al. 2000a). SNURF bound to DNA without an apparent nucleotide 
sequence specificity, and it interacted with both supercoiled and four-way junction DNA 
and recognized nucleosomes (Häkli et al. 2001). Deletion of amino acids 1-20 and 
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mutations R8-11A/K9A and R8A of SNURF protein abolished DNA binding activity and 
severely decreased transactivation on the Sp1 minimal promoter (Häkli et al. 2001). 
 
 
Table 5: Interaction partners of SNURF   
Factor Interaction domain of SNURF Reference 
AR aa 20-121 Moilanen et al. 1998b 
ERα aa 31-65, RING finger Saville et al. 2001 
TBP RING finger Moilanen et al. 1998b 
Sp1 RING finger Poukka et al. 2000a 
Gscl aa 39-125 Galili et al. 2000 
PATZ RING finger Pero et al. 2002 
HMGI(Y) full length protein Pero et al. 2000 
SBPB RING finger Lyngso et al. 2000 
TRPS1 aa 6-65 Kaiser et al. 2003 
SF1 aa 31-65 Curtin et al., unpublished 
 
 
Expression of SNURF 
 
SNURF is expressed as a single mRNA species of 3.0 kb in size in all human tissues 
analyzed. In addition to the ubiquitously expressed 3.0-kb transcript, another 1.0-1.6-kb 
testis-specific transcript is detected in rodents (Moilanen et al. 1998b). SNURF is 
expressed in murine embryonic tissues from E7.5 dpc on throughout the development, with 
high levels of expression in the developing gonads and nervous system (Galili et al. 2000). 
The gene coding for human SNURF/RNF4 maps at chromosomal region 4p16.3, which is 
associated with several genetic and neoplastic diseases (Chiariotti et al. 1998). The 47-kb 
spanning human RNF4 gene was located immeadiately proximal to the anonymous 
position D4S183, between the huntingtin (HD) and fibroblast growth factor receptor 3 
(FGFR3) genes (Chiariotti et al. 1998). 
 
Deletion at 4p16.3 between the markers D4S43 and D4S127, the region bearing the RNF4 
gene, was detected in breast carcinomas, and the loss of heterozygosity at 4p16.3 was 
common in bladder carcinomas (Elder et al. 1994, Shivapurkar et al. 1999). Interestingly, 
expression of SNURF was down-regulated in RAS-transformed cells (Zuber et al. 2000). 
Mutational activation of the RAS genes is important in the multi-step pathogenesis of 
several malignancies, such as pancreas, colon, lung, and myeloid cancers. Expression of 
SNURF was repressed in testicular germ cell tumors of yolk sac, embryonal carcinoma, 
and seminoma types (Pero et al. 2001). In addition, ectopically overexpressed SNURF 
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inhibited the growth of cultured human embryonal kidney (293T) and teratocarcinoma 
(NTERA-2) cells (Pero et al. 2001).  
 
RING finger proteins in ubiquitylation 
 
Ubiquitin is a 76-amino acid protein. Its successive covalent attachments to target proteins 
result in their degradation, endocytosis, or conformational alteration (Hershko and 
Ciechanover 1998, Varhavsky 1997, Weissman 2001). Protein modification by the 
ubiquitin pathway proceeds in a three-step fashion (for review, Hershko and Ciechanover 
1998, Varhavsky 1997, Weissman 2001) (Fig. 8). First, ubiquitin is activated by a 
ubiquitin-activating enzyme, E1. Secondly, the activated ubiquitin moiety is transferred to 
a cysteine residue of a ubiquitin-conjugating enzyme, E2, from which a ubiquitin ligase, 
E3, transfers it to the target protein. Several RING finger proteins and HECT (homology to 
the E6-AP carboxyl-terminus) domain ligases function as E3 ubiquitin ligases. E3 ligase 
facilitates the covalent attachment of ubiquitin to the substrate via the formation of an 
isopeptide bond between the C-terminal lysine of ubiquitin and ε-NH2 group of an internal 
lysine residue of the substrate. In subsequent reactions, several ubiquitin molecules are 
added to the substrate, and the polyubiquitin-tagged protein is degraded by the 26S 
proteasome.  
 
Many factors of the ubiquitylation pathway show remarkable evolutionary conservation, 
from yeast to mammalian species. The ubiquitin system participates in the regulation of 
several signal transduction processes, such as cell differentiation, cell cycle progression, 
endocytosis, immune response, programmed cell death, receptor down-regulation, and 
chromatin modification including DNA repair and gene silencing (Hershko and 
Ciechanover 1998, Weissman 2001). SNURF is auto-ubiquitylated in a RING domain-
dependent fashion and may mediate ubiquitylation, suggesting its potential function as an 
E3 ubiquitin ligase (Häkli et al., unpublished results). The Angelman syndrome-associated 
protein E6-AP functions as an E3 ubiquitin ligase, targets p53 protein specifically to 
degradation, and coactivates nuclear receptors (Nawaz et al. 1999, Scheffner et al. 1994). 
Inactivation of the E6-AP gene in mice resulted in reduced fertility in both genders with 
defects in sperm production and in ovulation, and tissue-selective steroid hormone 
resistance (Smith et al. 2002).  
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Fig. 8 Ubiquitylation pathway. First, ubiquitin is activated by the ubiquitin-activating enzyme E1 in a 
reaction that requires ATP hydrolysis to form a high-energy thiol ester linkage between the carboxyl-
terminus of ubiquitin and the cysteine of the active site of E1. Secondly, the activated ubiquitin moiety is 
transferred via transthiolation reaction to the ubiquitin-conjugating enzyme, E2, from which the ubiquitin 
ligase, E3, facilitates the transfer to the target protein. In subsequent reactions, several ubiquitin molecules 
are added to the substrate and the polyubiquitin-tagged protein is degraded by the 26S proteasome. Ubiquitin 
can be detached from the polyubiquitin chain or substrate by members of two deubiquitinating enzyme 
families: ubiquitin-terminal hydrolases (UCHs) and ubiquitin-specific processing proteases (UBPs) 
(Wilkinson 1997).  Modified from Hochstrasser, Science, 2000. 
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AIMS OF THE STUDY 
 
The physiological role of small nuclear RING finger protein SNURF (RNF4), a 
transcriptional coregulator, is largely unknown despite several in vitro interaction and 
expression studies reported. However, the expression of SNURF mRNA and protein to 
high levels in testis suggests a role for SNURF in reproduction. This thesis work aimed at 
studying the regulation of the SNURF gene expression during fetal gonad development, 
postnatal ovarian folliculogenesis and spermatogenesis, and in testicular germ cell tumors. 
The specific goals were as follows: 
 
• To study the expression of SNURF mRNA and protein during gonad determination 
and prenatal differentiation, as well as in postnatal ovarian and testicular 
development.  
 
• To characterize the main regulatory elements governing transcription from the 
murine SNURF gene. 
 
• To study the hormonal regulation of SNURF gene expression in vivo in rodent 
gonads. 
 
• To analyze the expression of SNURF and steroid receptors in human testicular 
germ cell cancer (TGC).   
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METHODS 
 
For detailed description of the materials and methods, the reader is referred to the original 
publications indicated in Table 6. In addition, some discussion on the methodology is 
included in the chapter ‘Results and Discussion’. 
 
 
Table 6: Methods used in the study Described in publication no. 
Cell culture and transfections I, IV 
Electrophoretic mobility shift assay (EMSA) I 
Immunohistochemistry II, III, IV 
In situ hybridization II, IV 
Northern blotting II 
Primer extension I 
Quantitative RT-PCR III, IV 
Recombinant DNA techniques and plasmid I, II, IV 
construction  
 
 
Tissue samples 
 
All animal experiments were approved by the appropriate institutional review boards of the 
University of Turku (II), University of Helsinki (IV), and Baylor College of Medicine 
(Houston, TX, USA) (IV). For the description of the hormone-treated animal models the 
reader is referred to Table 8. The gonad samples from the hormone-treated and wild-type 
mice and rats (n=2-3 in each group) were fixed in 4% paraformaldehyde and embedded in 
paraffin for preparation of 5-µm tissue sections for in situ hybridization and 
immunohistochemistry. The human and rat testicular specimens were snap-frozen in liquid 
nitrogen and stored at –70oC until RNA extraction. Study plan of the testicular germ cell 
cancer project (III) was approved by the ethics committee of the Helsinki University 
Central Hospital. Paired specimens of normal testis tissue and adjacent tumor tissue were 
obtained from 12 patients with TGC (seminomas n=8, non-seminomas n=4), who 
undervent surgery at the Department of Urology, Helsinki University Central Hospital, 
Helsinki, Finland. Informed consent was received from each patient. 
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Plasmids 
 
The SNURF promoter fragments –617/+111, -202/+111, -38/+111, -8/+111, +32/+111, 
and –38/+36 nt (numbering refers to the transcription initiation site) were cloned into the 
luciferase encoding pGL3-basic vector (Promega, Madison, WI, USA).  In reporter gene 
assays and cotransfections, 300-350 ng of the promoter constructs, 100 ng of pEVR-Sp1, 
pRc/CMV-Sp3, or pCB6-WT18A, and 50 ng of pCMVβ (Clontech, Palo Alto, CA, USA) 
were used per 3x104 cells per well.  
 
Cell culture and transfections 
 
COS-1 (American Type Culture Collection, ATCC), HeLa (ATCC), and mSC-1 cells (a 
gift from Prof. Ilpo Huhtaniemi, University of Turku, Finland) were maintained in 
Dulbecco’s minimal essential medium containing penicillin (25 000 U/l), streptomycin (25 
000 U/l), and 10% (vol/vol) fetal bovine serum. Twenty-four hours before transfection, the 
cells were seeded on 12-well plates (3x104 cells per well) with indicated expression 
plasmids and 50 ng of β-galactosidase encoding pCMVβ using FuGENE 6 reagent (Roche 
Molecular Biochemicals, Indianapolis, IN, USA). The cells were harvested 48 hours after 
transfection. Luciferase activities were measured with reagents from Promega using a 
Luminoskan RT reader (Labsystems, Helsinki, Finland) and β-galactosidase activities were 
determined according to Rosenthal (1987). The luciferase values were normalized by the 
β-galactosidase values.  
 
Electrophoretic mobility shift assay (EMSA) 
 
EMSA experiments were carried out with 1 µg of HeLa cell nuclear extract (4C Biotech, 
Belgium), 1.6 µg of poly(dI-dC)(dI-dC) (Amersham Pharmacia Biotech, Aylesbury, UK), 
and 32P-labeled promoter fragments –8/+111 nt and –38/+111 nt in 20 mM HEPES (pH 
7.9), 10% glycerol (vol/vol), 50 mM KCl, 0.5 mM EDTA, 1 mM DTT, 1 mM MgCl2, 0.5 
mM phenylmethylsulfonyl fluoride (PMSF), and 1 µM leupeptin. Reaction products were 
separated on 4% polyacrylamide gels run in 22.5 mM Tris-borate, 0.5 mM EDTA for 2-3 h 
at 200V at 22oC. In oligomer competition assays, nuclear extracts were preincubated with 
100-fold molar excess of non-radioactive double-stranded oligonucleotides encompassing 
indicated promoter regions or consensus binding sites for NF-κB, CREB, and Sp1. 
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Immunohistochemistry 
 
Paraffin-embedded sections of gonads were used for immunohistochemical staining with 
polyclonal anti-SNURF antibody raised against rat SNURF in rabbit (1:1000-1:2000 
dilution in Tris-buffered saline (TBS) containing 1% bovine serum albumin (BSA), 
Moilanen 1998b), and the positive cells were visualized using Vectastain Elite ABC kit 
(Vector laboratories, Burlingame, CA, USA) according to the manufacturer’s instructions. 
As a control, 500 ng of GST-SNURF were first incubated with the antibody (1:2000 
dilution) for 16 h at 4°C, and the resulting preadsorbed anti-SNURF antibody was used to 
monitor the specificity of staining. ERβ antigen was detected using anti-ERβ 503 antibody 
that was raised against human ERβ in chicken (a gift from Dr. Jan-Åke Gustafsson, 
Novum, Huddinge, Sweden, diluted to 1:1000 in phosphate-buffered saline (PBS) with 3% 
BSA and 0.05% Tween 20) and peroxidase-conjugated rabbit anti-chicken IgG (1:1000 
dilution in PBS and 2% rat normal serum) (Sigma-Aldrich, St. Louis, MO, USA). Samples 
were incubated with the primary antibodies at 4oC overnight. Peroxidase activity was 
visualized with diaminobenzidine as the substrate (Vector laboratories, Burlingame, CA, 
USA), and the sections were stained with Mayer’s hematoxylin, dehydrated, and mounted.  
 
In situ hybridization 
 
The tissue sections of gonads were deparaffinized, permeabilized, dehydrated, and 
hybridized to antisense and sense SNURF RNA probes (corresponding to nt 156–536 of 
murine SNURF cDNA, or to nt 234-967 and nt 968-1644 of rat SNURF cDNA) 
synthesized in the presence of [α-35S]UTP (Amersham Pharmacia Biotech, Aylesbury, 
UK). The tissue sections were incubated with 5x104 cpm of 35S-labeled probes in a total 
volume of 100 µl and incubated overnight at 55oC. Hybridization signals were detected 
after a 10-14-day exposure to NTB-2 emulsion (Eastman Kodak, Rochester, NY, USA) at 
4oC.  
 
Northern blotting 
 
Ten micrograms of total rat testicular RNA were size-fractionated in 1% denaturing 
agarose gel and transferred onto Hybond-N+ nylon membrane (Amersham Pharmacia 
Biotech, Aylesbury, UK). After hybridization with 32P-labeled SNURF probes 
(corresponding to nt 234-967 and nt 968-1644 of rat SNURF cDNA) at 68oC overnight, the 
blots were stripped and subsequently hybridized with 28S rRNA cDNA probe labeled with 
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[α-32P]dCTP (Amersham Pharmacia Biotech, Aylesbury, UK) by the random priming 
method (Prime-a-gene kit, Promega, Madison, WI, USA). 
 
Real-time quantitative RT-PCR 
 
Real-time quantitative RT-PCR was performed using the Lightcycler system, FastStart 
DNA Master SYBR Green I mix (Roche Molecular systems, Indianapolis, IN, USA), and 
indicated primers according to the manufacturer’s instructions. For detailed protocol of the 
RT-PCR reactions the reader is referred to Fig. 11. 
 
Granulosa cell cultures 
 
Granulosa cells were harvested by needle puncture from the ovaries of E2-primed (1.5 mg 
s.c. daily for 3 days) immature rats (aged 26 days). The cells were cultured on serum-
coated 12-well culture plates at a density of 0.5x106 cells per 1.5 ml in Dulbecco’s minimal 
essential medium:F12 containing 100 IU/ml penicillin and streptomycin. On the following 
day, the cells were washed and cultured in fresh serum-free medium containing FSH (50 
ng/ml, NIH FSH-16), testosterone (10 ng/ml), forskolin (10 µM), and/or PMA (20 nM) 
and harvested after selected time intervals for RNA extraction. 
 
Semi-quantitative RT-PCR 
 
Total RNA were extracted from whole ovaries of PMSG/hCG-primed immature rats, 
hypophysectomized (H) rats, and E2/FSH/hCG-primed H rats (from Harlan Sprague 
Dawley, Inc., Chicago, IL, USA), as well as from granulosa cells using Trizol reagent 
(Life Technologies, Inc., Grand Island, NY, USA). Semi-quantitative RT-PCR was 
performed using primers specific for SNURF and the ribosomal protein L19. Total RNA 
(500 ng) was reverse transcribed using oligo-d(T) primer and AMV-RT at 42oC for 75 min 
and 95oC for 5 min. DNA products were amplified in the presence of [α-32P]dCTP and Taq 
polymerase for 22 cycles at 94oC for 1 min, 60oC for 2 min, and 72oC for 2 min. The 
amplified DNA was resolved on a 5% polyacrylamide gel, which was dried, and exposed 
to X-ray film, and the signal intensities were quantified by using Storm 860 
PhosphorImager software (Molecular Dynamics, Sunnyvale, CA, USA). 
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RESULTS AND DISCUSSION 
 
Expression of SNURF during murine gonad determination and prenatal 
differentiation (IV) 
 
The murine gonad development begins at E10.5 dpc by migration of primordial germ cells 
to the urogenital ridges. The gonads first develop in a non-sex-specific manner, but by 
E11.0 dpc, the Sertoli cells express masculinizing transcription factors, and at E13.5 dpc, 
the testicular cords have been established (Capel 2000). Previously, Galili et al.  (2000) 
reported that SNURF mRNA was detected at high levels in murine embryos from E7.5 dpc 
onwards. To gain insight into the role of SNURF in gonad determination and 
differentiation, we analyzed the expression of SNURF mRNA in developing murine 
gonads at E10.5-E17.5 dpc by in situ hybridization. The expression of SNURF mRNA was 
detected at moderate levels in fetal gonads of both sexes from E10.5 dpc onwards. SNURF 
mRNA accumulated to high levels in the fetal testis by E15.5-E17.5 dpc, with the most 
intense signal being localized to testicular cords, indicating that SNURF mRNA 
accumulation was developmentally regulated. Immunohistochemical staining using 
polyclonal anti-SNURF antibody (Moilanen et al. 1998b) confirmed the presence of 
SNURF protein in gonocytes, Leydig cells, and some Sertoli cells and in oogonia and 
supporting cells in the fetal testes and ovaries, respectively, at E17.5 dpc. SNURF interacts 
with SF1, an orphan nuclear receptor essential for gonadogenesis expressed in pre-Sertoli 
cells from E10.5 dpc onwards (Curtin et al., unpublished results, Luo et al. 1994). 
Moreover, SNURF is able to indirectly facilitate transcription elicited by GATA4, that is 
expressed to high levels in Leydig cells and Sertoli cells during fetal testis development 
(Kaiser et al. 2003, Ketola et al. 1999). Interestingly, GATA4 enhances transcription from 
the Müllerian inhibiting substance gene by interacting directly with SF1 (Tremblay and 
Viger 1999). Thus, SNURF might regulate gonad development by modulating 
transcriptional responses elicited by SF1 and GATA4. 
 
Expression of SNURF in spermatogenesis (II, III) 
 
A variety of widely expressed transcription factors exhibit alternatively spliced testis-
specific transcript species. They may be differently regulated in gonads due to tissue-
specific alternative promoters, or by signals from cell-specific transcription factors (Daniel 
and Habener 1998, Schmidt and Schibler 1995). The SNURF gene encodes a 1.0-1.6-kb 
alternative transcript in adult rodent testis, in addition to the ubiquitous 3.0-kb transcript 
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(Moilanen et al. 1998b, Lyngso et al. 2000). We isolated the rat testis-specific SNURF 
mRNA sequence from the same cDNA library, from which the ubiquitous SNURF 
transcript was originally identified (Moilanen et al. 1998b). Both rat transcripts encode a 
full-length SNURF protein of 194 amino acids. The shorter rat SNURF mRNA is 
generated by the use of an alternative poly(A)+ sequence. Similarly, both murine SNURF 
transcripts encode the full-length SNURF protein and only differ in their 3’untranslated 
regions (Pero et al. 2003).  
 
To analyze whether expression of the SNURF gene was developmentally regulated during 
postnatal rat testis development, we performed in situ hybridization experiments using a 
series of rat testicular samples representing different developmental phases. The 3.0-kb 
SNURF mRNA was expressed from newborn to mature testis, whereas the 1.6-kb mRNA 
appeared only after postnatal day 30, as detected using transcript-specific RNA probes in 
in situ hybridization experiments. The 1.6-kb transcript was abundantly expressed in 
postmeiotic haploid round and elongating spermatids (step 4-11 spermatids), while the 3.0-
kb mRNA localized mainly to spermatogonia and somatic Leydig and Sertoli cells. In 
agreement with our data, Pero et al. (2003) detected the 3.0-kb SNURF transcript in 
murine spermatogonia and Sertoli cells, whereas the shorter transcript was seen in 
spermatogenic cell populations. We confirmed the cell type-specific expression of the 
SNURF transcripts by using methoxyacetic acid (MAA) treatment, which depletes 
spermatocytes at stages I-VI within 24 h of oral administration (Bartlett et al. 1988, Table 
8). In MAA rat model, the stages are devoid of spermatocytes on day 4 after the treatment, 
and on days 18 and 30 the stages lack round and elongating spermatids, respectively 
(Bartlett et al. 1988). The 3.0-kb SNURF mRNA remained constant in testis on post-
treatment days 4, 18, and 30. Interestingly, the level of the 1.6-kb SNURF transcript was 
markedly decreased on day 18, possibly due to the depletion of most of the SNURF-
expressing spermatids at stages IV-VI. MAA treatment provided additional evidence that 
the 3.0-kb and 1.6-kb SNURF mRNAs accumulated mainly in somatic cells and 
spermatogonia, and spermatids, respectively. 
  
SNURF protein was detected in moderate amounts in postnatal rat testis from day 20 
onwards (Fig. 9). It localized mainly to Sertoli cell nuclei before postnatal day 30, but from 
day 30 onwards nuclei of both Sertoli cells and spermatids were coated with polyclonal 
anti-SNURF antibody in agreement with the in situ hybridization data. Furthermore, the 
expression of SNURF protein was high at stages VII-VIII, IX-XII, and II-VI, and low at 
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stages XIII-I. In summary, SNURF protein was expressed in developmentally regulated 
fashion in the rat testis. 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Western blot analysis of SNURF protein expression during postnatal development of the rat 
testis. One hundred µg of total testicular protein/lane were resolved on SDS-PAGE, transferred onto 
nitrocellulose membrane, and immunoblotted using polyclonal anti-SNURF antibody (1:10 000 dilution). 
The immunocomplexes were visualized with horseradish peroxidase-conjugated goat anti-rabbit IgG 
antibody (1:10 000 dilution, Zymed laboratories, South San Francisco, CA, USA) and ECL detection system 
(Amersham Pharmacia Biotech, Aylesbury, UK). The membrane was stripped according to the 
manufacturer’s instructions and reprobed with mouse anti-actin antibody (ICN Biochemicals, Aurora, OH, 
USA) to monitor sample loading and transfer. d; days after birth, NB; newborn. 
 
SNURF was originally identified as an AR-interacting protein in a yeast two-hybrid 
screen, and it was found to colocalize with AR in the epithelial cells of the prostate 
(Moilanen et al. 1998b). Since AR is not expressed in the male germ cells, expression 
pattern of SNURF suggests that its function is not restricted to AR-mediated transcription 
in testis. In addition to steroid receptors, SNURF interacts with other transcription factors 
expressed in male germ cells, such as Sp1, and may thus act as a transcriptional 
coregulator of several signal transduction pathways in the germ cells (Hapgood et al. 
2001). SNURF is autoubiquitylated, may function as an E3 ubiquitin ligase, and it binds to 
single-stranded and double-stranded DNA and histones H3 and H4 (Häkli et al. 2001, 
Häkli et al., unpublished results). It is tempting to speculate that SNURF participates in 
protein degradation and chromatin compaction during spermiogenesis.  
 
Immunohistochemical staining using anti-SNURF antibody demonstrated the expression of 
SNURF protein in Leydig cells, Sertoli cells, as well as in round and elongating spermatids 
in adult human testis. In addition, SNURF protein was detected in spermatogonia and 
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spermatocytes at low levels in the human testis. However, on the contrary to the rodent 
Leydig cells showing slight immunoreactivity, human Leydig cell nuclei stained 
intensively with the anti-SNURF antibody (III). In testes, SNURF localized mainly to cell 
nuclei, although predominantly cytoplasmic expression was reported in developing murine 
neural structures, such as dorsal root ganglia and the neural tube, and in human primary 
fibroblasts (Galili et al. 2000, Kaiser et al. 2003). Since SNURF is phosphorylated by 
casein kinase II in vitro and is ubiquitylated in vitro (Moilanen et al. 1998b, Häkli et al., 
unpublished). Subcellular localization of SNURF may be regulated by protein-protein 
interactions elicited by covalent modifications in specific cell types. Interestingly, SNURF 
enhanced nuclear transport of AR and association of AR to nuclear matrix in COS-1 cells 
by an unknown mechanism (Poukka et al. 2000b). Other nuclear receptor coregulators 
expressed to high levels in male germ cells include PIASxα, PIAS1, and AIB3/RAP250 
(Yan et al. 2003, Zhang et al. 2003). In addition, GRIP1/TIF2 was expressed in Sertoli 
cell-specific fashion in murine testis (Gehin et al. 2002).  
 
Expression of SNURF in murine postnatal ovary (IV) 
 
Several factors important for spermatogenesis, such as c-Kit receptor and Kit ligand and 
steroid receptors, play also important roles during folliculogenesis (Richards 2001). The 
abundant amounts of SNURF mRNA and protein in fetal gonads and in spermatogenesis 
prompted us to investigate the expression of SNURF mRNA during ovarian development. 
A series of ovarian specimens from newborn to mature mice were subjected to in situ 
hybridization using SNURF RNA probe. We detected SNURF mRNA throughout 
folliculogenesis appearing at high levels in the oocytes of preantral follicles from postnatal 
day 14 onwards. SNURF mRNA was detected at moderate levels in granulosa cells of 
preantral, antral, and Graafian follicles and in the luteal gland. Moreover, 
immunohistochemical staining using anti-SNURF antibody demonstrated SNURF protein 
in oocytes, in granulosa and luteal cells, as well as in theca and interstitial cells. 
Unfortunately, studies of SNURF expression in human ovary and ovarian tumors was out 
of reach in this work. SNURF protein colocalizes with AR, ERβ, and PR in the granulosa 
cells, ERα in the oocytes and in the corpus luteum, suggesting that SNURF facilitates 
steroid receptor-mediated signaling during follicle maturation and luteinization. Some 
other coregulator proteins have already been implicated in the regulation of female 
fertility, as exemplified by Nrip1, the null mutants of which are infertile due to ovulatory 
failure (White et al. 2000). Moreover, deletion of the gene encoding SRC-3 resulted in 
female subfertility (Xu et al. 2000). In addition, female mice lacking TAFII105, a TATA-
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binding protein associated factor, are infertile because of a defect in folliculogenesis 
(Freiman et al.  2001).   
 
 
Table 7. Expression of SNURF mRNA during gonad development   
Prenatal murine Male           Female     
development Germ cells (pre)SC LC       Germ cells GC CL 
E10.5 dpc + + -       + + - 
E12.5 dpc + + -       + + - 
E13.5 dpc + + +       + + - 
E15.5 dpc ++ + +       + + - 
E17.5 dpc ++ + +       + + - 
Newborn mice + + +       + + - 
Postnatal rat development          
NB + + -       nd nd nd 
5d + + -       nd nd nd 
10d + + -       nd nd nd 
20d + + +       + + nd 
30d ++ + +       nd nd nd 
40d ++ + +       nd nd nd 
60d ++ + +       nd nd nd 
Postnatal murine development          
7d nd nd nd      + + - 
14d nd nd nd      ++ + - 
25d nd nd nd      ++ + - 
59d nd nd nd      ++ + + 
11 wk nd nd nd      ++ + + 
Adult human          
 ++ + ++      nd nd nd 
nd; not determined, SC; Sertoli cell, LC; Leydig cell, GC; granulosa cell, CL; corpus luteum. 
 
 
Posttranslational modifications, such as phosphorylation, acetylation, sumoylation, and 
ubiquitylation, modify steroid receptor-mediated signaling by affecting the transcriptional 
activity and/or subcellular localization of the receptors. In the periovulatory granulosa 
cells, ubiquitin-related modifier SUMO-1 and PR interacted in vivo, and inhibition of 
SUMO-1 expression by luteinizing hormone receptor stimulation was linked to 
periovulatory induction of PR levels (Shao et al. 2003). Recently, ret finger protein-like 4 
(Rfpl4), exhibiting a RING finger-like structure with E3 ubiquitin ligase activity, was 
shown to regulate proteosome-mediated degradation of maturation-promoting factor 
(MPF), a heterodimer of p34Cdc2 and cyclin B1, during the progression of meiotic cell 
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cycle in murine oocytes (Suzumori et al. 2003). As SNURF possesses a RING finger 
domain present in many E3 ubiquitin ligases, the abundant expression of SNURF in the 
maturing oocytes might implicate in a role in regulation of oocyte meiosis. Although 
proteasomal degradation has been well established in the steroid receptor-dependent 
transactivation (Lonard et al. 2000), SNURF does not appear to mediate ubiquitylation of 
AR (Tian et al., unpublished results). 
 
Transcriptional regulation of the murine SNURF gene (I) 
 
Transcriptional regulation is mediated via promoter regions usually located upstream of 
transcription initiation sites of the target genes. The diversity of developmental and tissue-
specific signals is conveyed by binding of a variety of cellular transcription factors to the 
specific target sequences on the promoter regions, as exemplified by binding of AR to 
AREs on the PEM homeodomain gene promoter (Rao et al. 2003). Along with the 
identification of the two alternative SNURF transcripts in rodent testis (Moilanen et al. 
1998b), we became interested in the regulatory determinants governing transcription from 
the murine SNURF gene. To identify the regulatory regions responsible for the generation 
of murine SNURF transcripts, 0.7 kb of the SNURF promoter was isolated. Alternative 
transcripts may be generated using alternative transcription start sites or different tissue-
specific promoters of the gene, as exemplified by the testis-specific promoter of TBP 
(Schmidt et al. 1997). To determine the transcription start sites of the SNURF gene, we 
performed primer extension assays using two different antisense oligomers and mouse total 
testicular RNA as a template. A single primer extension product was detected using both 
primers, suggesting that a single promoter governs the generation of both SNURF 
transcripts. In addition, Pero et al. (2003) published primer extension data that agree with 
our observations, in that the murine RNF4 transcripts also originate from the same 
promoter. 
 
There are several GC-rich elements within the SNURF promoter characteristic of 
housekeeping genes, but a consensus TATA box or a CCAAT box were not located in the 
vicinity of the transcription start site. To determine the elements critical for basal promoter 
activity, different fragments of the promoter were cloned in front of the luciferase gene and 
transfected into mammalian cells. The longest construct (–617/+111 nt) showed very 
strong basal activity in HeLa, COS-1, and mSC-1 cells. The activity of the region –38/+36 
nt exhibited 29-43% of the maximal promoter activity in mammalian cells, indicating that 
the fragment harbored the elements critical for the basal activity of the SNURF promoter. 
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Detailed sequence analysis revealed a GC box at +9 nt and a NF-κB consensus site at -8 nt 
within the core promoter (Fig.10). The GC box was conserved in the human RNF4 gene, 
suggesting functional importance of the element (Chiariotti et al. 1998). Although SNURF 
is expressed at high levels in spermatids, consensus elements for the testis-specific 
transcription factor CREM were not found within the SNURF promoter region (data not 
shown). 
 
Binding of nuclear proteins to the SNURF promoter was examined by electrophoretic 
mobility shift assay using 32P-labeled probes corresponding to –8/+111 nt and –38/+111 nt. 
Using nuclear extract, we detected one major and few minor nuclear protein-DNA 
complexes, which were abolished by the addition of a 100-fold molar excess of unlabeled 
probes or double-stranded –8/+34 or –8/+24 oligomers. Interestingly, a non-radioactive 
Sp1 consensus oligomer reduced the formation of the major protein-DNA complex 
indicating that the Sp family members might bind to the promoter. NF-κB and CREB 
consensus oligomers did not challenge the probe markedly. Deletion of the proximal GC 
box from the probe –8/+111 abolished nuclear protein binding to the SNURF promoter and 
reduced promoter activity to 21% and 13% of the corresponding wild-type construct 
activity in COS-1 and HeLa cells, respectively. 
 
In search for factors regulating SNURF gene activity, we transfected plasmids encoding 
Sp1, Sp3, and WT1 gene products, factors binding to GC-rich elements, with the promoter 
constructs into mammalian cells (Hapgood et al. 2001). Ectopically expressed Sp1 
marginally stimulated the SNURF promoter in HeLa cells, an effect not seen in the 
presence of a construct bearing the mutated proximal GC box. WT1, essential for 
urogenital development, activated the –8/+111 fragment >4-fold in HeLa cells. 
Interestingly, the WT1 gene product is expressed concomitantly with SNURF at E10.5 dpc 
in genital ridges of both sexes (Kreidberg et al. 1993). Colocalized expression of SNURF 
and WT1 during early gonad development supports the possibility that SNURF gene 
activation is dependent on WT1 signaling in fetal gonads in vivo. SNURF binds to Sp1, 
which interacts with components of the TFIID complex and several transcription factors, 
such as NF-κB and GATA-1 (Chiang and Roeder 1995, Emili et al. 1994, Gill et al. 1994). 
The critical GC element on the SNURF promoter may thus mediate activation by tissue-
specific and developmental signals in addition to constitutive induction (Hirano et al. 
1998, Merika et al. 1995). Interestingly, Sp1 and Sp3, present in the male germ cells, are 
among the factors responsible for the testis-specific expression of PIASx coregulators, and 
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they may thus also stimulate the SNURF promoter in the spermatogenic cells (Santti et al. 
2003). 
 
 
 
 
 
 
 
 
Fig. 10 Schematic presentation of the murine SNURF core promoter. The TATAless proximal promoter 
contains GC boxes starting at +9 nt and –25 nt, and a putative NF-κB site at –8 nt. The GC element at +9 nt 
was critical for the proximal SNURF promoter activity, and Sp1 and WT1 gene products were found as 
potential activators of the murine SNURF gene in mammalian cells. 
 
Hormonal regulation of SNURF gene expression in vivo in rodent gonads (II, IV) 
 
SNURF interacts with steroid receptors augmenting their function and is expressed to high 
levels in steroid hormone target tissues, the testis and the ovary. Thus, we hypothesized 
that SNURF mRNA might be regulated by steroids in vivo. Despite the presence of several 
steroid receptor response element half-sites in the murine SNURF promoter (at nt +58, -50, 
-238, -407, and –431 for AR, and +18 and –123 for ER, respectively), ectopically 
expressed AR or ER in the presence of testosterone or estradiol, respectively, did not affect 
the activity of SNURF promoter fragments in mammalian cells (data not shown). 
However, administration of ethylene dimethane sulfonate (EDS), which depletes testicular 
Leydig cells within 24 h, resulted in undetectable SNURF mRNA levels between post-
treatment days 2 and 15 in rat testis concomitantly with the declining testicular testosterone 
(T) levels (Teerds 1996, Table 8). Twenty days after the EDS administration, by the time 
that the Leydig cells had recovered their function, SNURF transcript levels accumulated in 
concert with the raising T levels. Rats, that received EDS and T implants simultaneously 
exhibited higher circulating T levels and 3-5-fold increased testicular SNURF mRNA 
levels, respectively, compared to control rats. Steroid hormone response elements are often 
located up to 10 kb upstream of the transcription start site, and the cis-element responsible 
for androgen-regulation of testicular SNURF mRNA could be located further upstream of 
the SNURF promoter analyzed in the transient transfections. The effects of testosterone 
may also be mediated indirectly. Steroid receptors interact with other transcription factors, 
+36 bp
GCGCGACTGGCGGCACTCTCGCGGGAAGTGGAAGCTCCCGCAAGCAGGCGGGGCGTGACCGGAAGAAGGTGTAT
-38 bp +1 bp
GC box                                NF-κB                     GC box
Sp1 WT1
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such as NF-κB, and influence their transcriptional activity sometimes even without binding 
to DNA elements, referred to as ‘transcriptional cross-talk’ (Göttlicher et al. 1998). 
Androgen action to germ cells is mediated through Sertoli cells and Leydig cells that 
express AR, and accumulation of SNURF in germ cells is likely to be regulated indirectly 
by paracrine signaling from the neighboring cells. However, ERβ is expressed in male 
germ cells and the effects of androgens could alternatively be conveyd to the germ cells by 
conversion to estrogens through the action of CYP450 aromatase present in the 
spermatogenic cells (Enmark et al. 1997). Interestingly, testosterone has been shown to 
stimulate the expression of aromatase mRNA in the purified rat germ cells (Bourguiba et 
al. 2003).  
 
In the ovary, estradiol is produced in the granulosa cells by aromatization of the androgen 
precursors diffusing from the neighboring theca cells (Richards 2001). Because 
testosterone increased SNURF mRNA level in rat testis either by an indirect mechanism or 
via conversion to estrogens, we sought to study whether estradiol regulates the 
accumulation of SNURF mRNA in vivo in the murine ovary. In the mouse model, PMSG, 
a hormone with both FSH and LH-like activity in the rodents, stimulates the growth of 
preovulatory follicles that synthesize increased amounts of estrogen (Sztein et al. 2000, 
Table 8). We exposed 3-week-old immature female mice to 2.5 IU of PMSG, that 
marginally attenuated the SNURF mRNA within 48 h after administration, whereas a 
subsequent injection of 2.5 IU of hCG, mimicking the preovulatory LH surge, slightly 
augmented ovarian SNURF mRNA content. However, as determined by semi-quantitave 
RT-PCR, SNURF mRNA level was not dramatically changed in whole ovaries of 
immature intact rats treated with PMSG and hCG. 
 
The ovaries from mice treated daily with 125 µg of diethylstilbestrol for 3 days increased 
SNURF mRNA levels in oocytes compared to control mice treated with vehicle, an effect 
that was blocked by the pure antiestrogen ICI 182,780, suggesting that expression of the 
SNURF gene was controlled by ER-dependent signaling in the oocytes (Jain et al. 1999). 
The levels of SNURF mRNA remained unchanged in the ovaries of female mice treated 
with ICI 182,780 alone compared to control mice, implying that estrogen-dependent 
signaling is not the only mechanism that regulates SNURF gene expression in oocytes. 
Moreover, ERα, that is expressed in the oocyte, did not stimulate SNURF gene activity in 
the presence of estradiol in mammalian cells of non-ovarian origin (I). 
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Table 8: Hormone treatments in animal models 
model hormone treatment Consequence 
MAA 650 mg/kg p.o. single dose Depletion of spermatocytes at 
(Bartlett et al. 1988) stages I-VI after 24 h, lack of round 
and elongating spermatids 
 18 and 30 days after treatment, 
respectively. 
EDS 75 mg/kg i.p. single dose Depletion of Leydig cells within 
(Teerds 1996) 24 h. Testosterone undetectable   
 between days 2 and 15. 
PMSG + hCG 2.5 IU PMSG i.p. + after 48 h Preovulatory follicles 48 h after 
(Sztein et al. 2000) 2.5 IU hCG i.p. PMSG and 5 h after hCG, post- 
 ovulatory follicles 20 h after hCG, 
 luteinizing follicles 5 d after hCG 
DES 125 µg s.c. daily for 3 days Stimulation of granulosa cell  
(Heikinheimo 1997) proliferation 
ICI 182,780 50 µg s.c. daily for 3 days Inhibition of estrogen-mediated 
(Jain et al. 1999) granulosa cell proliferation 
Hypophysectomized 
rats (Zhou et al. 
1995) 
1.5 mg E2 s.c. daily for 3 days + 
1.0 µg FSH i.p. twice daily + 10 IU 
hCG i.p. 
Preovulatory follicles 48 h after 
FSH, postovulatory follicles 16 h 
after hCG, luteinizing follicles 24 h 
after hCG 
 
To confirm the hormone-dependent regulation of SNURF mRNA observed in the whole 
murine ovary in vivo, we studied regulation of SNURF mRNA in hypophysectomized (H) 
rats (Zhou et al. 1995). In the PMSG model, it is difficult to dissociate the effects of the 
steroid from those of the gonadotropin. In the H rat model, E2 is required to stimulate 
granulosa cell proliferation and formation of the preantral follicles, which are highly 
responsive to FSH (Zhou et al. 1995). After hypophysectomy, SNURF protein levels 
declined in granulosa cells in vivo as determined by immunohistochemical staining, 
whereas SNURF was constitutively expressed in rat oocytes. Treatment of H rats with E2 
for 3 days restored SNURF protein expression in granulosa cells to some extent, but did 
not increase SNURF protein levels in the oocytes. This provided further evidence that 
basal activity of the SNURF gene in the oocytes was regulated in an estrogen-independent 
fashion. On the other hand, estradiol-mediated stimulation of SNURF gene expression 
might not be clearly detectable at the protein level by immunohistochemical analysis. 
Granulosa cells were isolated from ovaries of the H rats before and after hormonal 
stimulation and were used as a source of total RNA for semi-quantitative RT-PCR. 
SNURF mRNA levels were increased in E2-primed granulosa cells by 3-fold, as 
determined by semi-quantitative RT-PCR, and were increased further by 12 h after an 
additional treatment with FSH and hCG. To the best of our knowledge, the specific genes 
regulated by estradiol in the oocyte have remained speculative, but estrogen-dependent 
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genes in the granulosa cells include cyclin D2, cyclin E, ERβ, Foxo1 (FKHR), Foxo3 
(FKHRL1), and IGF-R1β (Castrillon et al.  2003, Richards 2001, Richards et al. 2002, 
Robker and Richards 1998, Sharma et al. 1999). Several estrogen-regulated genes, such as 
ERβ and cyclin D2, are overexpressed in ovarian granulosa cell tumors, that are often 
hormonally active secreting estrogens (Chu et al. 2000, Sicinski et al. 1996). SNURF, 
regulated by steroids and repressed in RAS-transformed cells and testicular tumors, might 
also contribute to ovarian tumorigenesis (Pero et al. 2001, Zuber et al. 2000). Taken 
together, SNURF gene expression is regulated in part by estrogen in rodent oocytes and 
granulosa cells in vivo.  
 
 
Table 9. Genes induced by testosterone or estradiol in rodent gonads/gonad-derived cells 
Androgen-regulated genes reference 
SNURF Yan et al. 2002 
PIASx Yan et al. 2003 
PEM Rao et al. 2003 
Aromatase Bourguiba et al. 2003 
5α-reductase1 Pratis et al. 2003 
Estrogen-regulated genes reference 
SNURF Hirvonen-Santti et al., submitted. 
ERβ Sharma et al. 1999 
Cyclin D2 Robker and Richards 1998 
Foxo1 (FKHR) Richards et al. 2002 
Foxo3 (FKHRL1) Richards et al. 2002 
IGF-R1β Richards et al. 2002 
Cyclin E Robker and Richards 1998 
 
 
To study intracellular signaling mechanisms regulating SNURF gene activation in 
granulosa cells, E2-primed granulosa cells were treated with the LH agonists forskolin and 
PMA, that are known to induce several genes, such as progesterone receptor, COX-2, AP1 
factors, and Egr-1, in preovulatory cells (Ochsner et al. 2003, Russell et al. 2003, Sharma 
et al. 2001, Sriraman et al. 2003). Moreover, the changes in SNURF mRNA were analyzed 
during granulosa cell differentiation in response to FSH and testosterone exposure. 
Forskolin and PMA transiently stimulated SNURF gene expression at 4 h after the 
treatment and induced SNURF in differentiated granulosa cells (i.e., in cells expressing 
markers, such as aromatase and LH receptor, of preovulatory phenotype) at 48 h after the 
FSH/T treatment. Furthermore, SNURF mRNA level was down-regulated in luteal cells 
when compared to preovulatory granulosa cells. These data suggest that SNURF, 
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interacting with PR essential for ovulation (Moilanen et al. 1998b), may play a role in 
ovulation.  
 
Expression of SNURF and estrogen receptor β in human testicular germ cells and 
testicular tumors (III, IV) 
 
The onset of the testicular germ cell malignancies at adolescence implicates in a fetal 
origin of the disease, and endogenous or environmental estrogens have been suggested to 
contribute to tumorigenesis (Sharpe 2003). Fetal exposure to excess of estrogens could 
suppress testosterone production and AR expression in the fetal testis as well as inhibit 
fetal Leydig cell gene expression, e.g. insulin-like factor-3 (InsL3) production (Nef and 
Parada 2000, Sharpe 2003). The role of androgens, essential for the normal testicular 
development and spermatogenesis, is largely unknown in testicular cancer development. 
Since the testicular expression pattern of SNURF implicated a role in prenatal gonocyte 
differentiation and spermatid maturation, we determined SNURF mRNA levels in 12 
paired normal testis-testicular germ cell cancer samples by real-time quantitative RT-PCR 
(Fig. 11). In addition to SNURF, we analyzed levels of mRNAs encoding ERβ, AR, 
PIAS1, and PIASx in the TGC specimen pairs. We found statistically significant 
repression of ERβ mRNA by 59% in seminomas (p=0.017, Wilcoxon signed ranks test) 
and down-regulation of SNURF/RNF4 and AR mRNA by 67% and 75%, respectively, in 
seminomas and teratocarcinomas (p=0.034 for both). In addition, the mRNA coding for 
ERβcx/β2 isoform was down-regulated in TGC samples (data not shown), whereas PIASx 
and PIAS1 mRNA levels were unaltered in TGC. We also examined the levels of cyclin 
D2 in our TGC material, and in agreement with previously reported observations, we 
found overexpression of cyclin D2 mRNA with an average increase of 6.8-fold. However, 
in our small patient group, overexpression of cyclin D2 remained statistically non-
significant (p=0.136). No statistically significant association was observed between ERβ 
and SNURF mRNA in seminomas, or between AR and SNURF mRNA levels in all 
tumors, respectively (data not shown). 
 
ERβ and SNURF protein levels were also repressed in local pT1 seminomas as judged by 
immunohistochemical analysis. Our results confirm and complement the observations of 
Pero et al. (2001), who reported reduced expression of SNURF in TGC of yolk sac, 
embryonal carcinoma, and seminoma types. In normal human testis, ERβ protein localized 
to primary spermatocytes and round spermatids as previously described (Saunders et al. 
2002). Recently, Pais et al. (2003) reported diminished expression of ERβ in seminomas, 
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embryonal cell carcinomas, and mixed germ cell tumors. Repressed ERβ mRNA and 
protein levels were reported in prostate cancer (Latil 2001). However, ERβ knockout male 
mice reproduced normally and showed prostatic hyperplasia, but did not exhibit testicular 
tumors (Weihua et al. 2001). The loss of AR mRNA in tumor samples probably reflects 
their cellular composition, i.e., the absence of AR-expressing Sertoli and Leydig cells. 
Accordingly, Tfm male mice bearing the mutated AR gene and AR knockout male mice 
showed Leydig cell hyperplasia, but no germ cell-derived cancer was reported (Lyon et al. 
1975, Yeh et al.  2002). To our best knowledge, expression of other classical nuclear 
receptor coregulators has not been studied in testicular germ cell cancer. However, several 
studies indicate altered coregulator mRNA expression in hormone-dependent breast, 
ovarian, and prostate cancers (Anzick et al. 1997, Lee et al. 1999, Zhu et al.  1999), as 
exemplified by overexpression of SRC-1 and TIF2/GRIP1 proteins in hormone-refractory 
prostate cancer (Gregory et al. 2001). Examples of genes with altered expression in 
testicular germ cells tumors are presented in Table 10. 
 
 
Table 10. Examples of genes with altered expression in TGC 
Gene Expression in TGC vs. normal Reference 
SNURF down-regulated Hirvonen-Santti et al. 2003 
ERβ down-regulated Hirvonen-Santti et al. 2003 
Cyclin D2 up-regulated Schmidt et al. 2001 
CDK4 up-regulated Schmidt et al. 2001 
Cyclin E down-regulated Schmidt et al. 2001 
CDK2 down-regulated Schmidt et al. 2001 
GRB7 up-regulated Skotheim et al. 2002 
c-KIT down-regulated Rajpert-de Meyts et al. 1994 
Ret finger protein down-regulated Tezel et al. 2002 
 
 
Immunoreactivity of ERβ and SNURF proteins were detected in the gonocytes in murine 
fetal testis from E15.5 dpc and E10.5 dpc onwards, respectively, in agreement with the 
expression of ERβ in Sertoli cells and gonocytes at midgestation in fetal human testis 
(Gaskell et al.  2003). Therefore, already prenatal disturbances in the regulation of estrogen 
signaling and SNURF expression may play a role in the early stages of TGC development. 
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Fig. 11 Quantification of human SNURF gene expression using real-time RT-PCR with Lightcycler 
system (Roche Molecular Systems, Indianapolis, IN, USA). Lightcycler measures fluorescent signals, that 
are produced proportional to the concentrations of the PCR products. The higher the cDNA concentration of 
the template, the earlier a significant accumulation of the PCR product occurs, and thereby the earlier the 
fluorescent signal is measured. After the PCR run, logarithmic values of fluorescence are plotted against 
cycle number. Top: A logarithmic plot of fluorescence above noise level during amplification. Serially 
diluted (1:5) standard contained approximately 60 ng, 12 ng, 2.4 ng, and 0.48 ng of normal human testis 
cDNA. Total RNA from testis samples was extracted using Trizol reagent (GIBCO BRL, Life Technologies) 
and phenol-chloroform extraction according to the manufacturer’s recommendations. Three µg of total testis 
RNA were annealed to 50 ng of oligo-d(T)12-18 primer (Amersham Pharmacia Biotech, Aylesbury, UK) at 
70oC for 10 min, and cDNA synthesis was carried out with 5-10 U of avian myeloblastosis virus reverse 
transcriptase (AMV-RT, Promega, Madison, WI, USA) at 50oC for 1 h and subsequently at 42oC for 1 h. 
Thermocycling was carried out in a 20-µl reaction volume containing 0.5 µM primers, 3.5 mM MgCl2, 2 µl 
of FastStart DNA Master SYBR Green I mix (Roche Molecular Systems, Indianapolis, IN, USA) and 2 µl of 
template cDNA. To avoid amplification of genomic DNA, the forward and reverse primers were designed to 
represent different exons. Human chromosome 1 contains an intronless SNURF pseudogene, but a number of 
mismatches in the pseudogene enabled the design of primers specific for the bona fide SNURF gene.  No 
amplification of the product was seen in the absence of reverse transcriptase. Bottom: The crossing points 
(cycle number), plotted against the logarithm of cDNA copy number to construct the standard curve, with the 
help of which the concentrations of unknown patient samples were determined.  
   60   12  2.4   0.48  
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Moreover, the majority of seminomas (7/8) in this study were early stage pT1 tumors 
further indicating that dysregulation of SNURF and ERβ could be an early event in 
testicular tumorigenesis. It is believed that the germ cells pass through a carcinoma in situ 
stage before differentiating into a seminoma or a non-seminoma, and because SNURF is 
repressed in the major TGC types, it could be down-regulated already in the early stages of 
TGC (Fig. 12, Masters and Köberle 2003).  
 
In summary, our results suggest that ERβ and SNURF might contribute to the development 
of TGC. Further investigation with larger testicular germ cell cancer sample series are 
needed to elucidate the roles of SNURF and ERβ during the development and progression 
of TGC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12 Hypothetical model of SNURF gene expression in testicular germ cell cancer development. 
SNURF mRNA, expressed to high levels in fetal testicular gonocytes, was down-regulated in both 
seminomas and non-seminomas, suggesting that repression of the SNURF gene is an early event in testicular 
tumorigenesis. Model modified from Masters and Köberle, Nature Reviews Cancer, 2003.
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CONCLUDING REMARKS 
 
Gene expression data provide clues in definition of biological gene functions. To gain 
insight into the role of SNURF in reproduction, this thesis work characterized the temporal 
and spatial expression pattern of SNURF during rodent prenatal and postnatal gonad 
development as well as in human testicular germ cell tumors. Importantly, the results 
showed evidence for the regulation of SNURF gene expression in response to steroids and 
pituitary gonadotropins in vivo in the rodent gonads. This implies that SNURF may play a 
role in gonadal physiology, such as germ cell maturation and ovulation. The main results 
of the study are summarized below. 
 
• SNURF mRNA is expressed to high levels in fetal and in postnatal germ cells as 
well as to lower levels in somatic cells in rodent gonads of both sexes. 
 
• Transcription from the murine SNURF gene was governed by a single promoter, 
which showed very strong basal activity in reporter gene assays in mammalian 
cells. A proximal GC box at +9 nt relative to the transcription start site was found 
to be critical for transcription from the murine SNURF gene. Sp1 and WT1 
transcription factors were identified as potential activators of the SNURF gene. 
 
• SNURF mRNA levels are regulated by testosterone in vivo in the rat testis and by 
gonadotropins and estrogen in vivo in the rodent ovary. 
 
• SNURF protein colocalizes with ERβ in fetal and postnatal male germ cells, and 
the expression of SNURF and ERβ mRNA and protein is down-regulated in human 
testicular germ cell tumors. 
 
The study of the SNURF gene expression during gonad development and in testicular 
tumors offered an exciting area for basic research, the results of which are relevant to our 
understanding of steroid receptor-mediated signaling, reproduction, infertility, and 
testicular tumor development and progression. However, further studies using genetically 
modified mouse models are required for confirmation of the biological significance of the 
SNURF coregulator in reproduction and development. Furthermore, research with large 
tumor sample series is required for assessing the role of SNURF in hormone-dependent 
tumorigenesis.
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